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In this chapter the thesis scope as well as the current key concepts related to this dissertation
are introduced. In addition, the thesis structure is outlined.
1.1 Thesis scope
One of the main challenges in software engineering is to develop systems capable
to adapt to the continuos changes in their environment. This problem is present in
software systems for biomedical research in cell systems. In biomedical research, the
study of cellular systems on large scale is called Cytomics, High-Throughput screening
(HTS) is one of the most common techniques in Cytomics for target validation. HTS
has to face that challenge due to the diversity and the emergence of new technologies in
the context of data, roles, hardware, software tools, techniques, algorithms, protocols,
etc. Additionally, the extremely large and growing volumes of data produced in these
experiments complicate the exploration, interoperability, understandability, sharing
and reusability of the data. Therefore, there is an urgent need to design and develop a
comprehensive data management platform for experiments in Cytomics. This thesis
focuses on the study of how to organize the data managed in Cytomics in an optimal
and yet flexible manner, so that these challenges can be tackled while taking care of an
appropriate organization of the heterogeneous data and then providing the necessary
tools and software to facilitate the extraction of meaningful data from these large
repositories.
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1.2 HTS experiments workflow
In drug discovery, an HTS workflow is a sequence of operations and activities required
to identify starting points for drug design or also called hits. These sequence consist of
five stages: (YLL+11): (1) Experiment Design, (2) Wet-lab, (3) Image acquisition, (4) Image
analysis and (5) Data analysis.
1.2.1 Experiment Design
The key component in HTS is the “plate”; this is basically a small container that features
a grid of wells and it is considered the principal information carrier of the experiment
(c.f. 1.2). A spreadsheet application is used to create a layout of the plate in order to
store practical information about the treatment introduced for each well in the cell
culture plate. Figure 1.1 displays the design of a 96 well plate; details of the metadata
are linked to each well therefore this is also called “plate design”. The “plate design”
contains the input data for the plate e.g. metadata and allows to link the output of
the plate e.g. image files. Figure 1.1 shows a brief description of the plate design.
Wells are identified by a row from “A” to “H” and a column from “1” to “12”. A
colour-coded notation in the plate design is used which facilitates the readability of
the basic metadata linked to the experiment. For this experiment the MCF7 cell line
is used and per well specific genes are switched off; i.e. knocked down, by the use of
siRNA transfection which are represented by the not colour-coded wells. The negative
controls are shown in light yellow, the positive control for transfection is in green, and
the positive control for knockdown and the noco-assay is in red e.g. Dynamin2. The
cells from wells B1 to B6 have been transfected with siGFP (light yellow). Wells B1 and
B2 were additionally treated with DMSO while wells B3 and B4 have been treated with
Nocodazole.
Figure 1.1: Design of a 96 wells plate for an experiment using MCF7 wt cells
1.2.2 Wet-lab
Based on the design stage, one or more plates are used during the experiment. During
the experiment, the in vitro cell lines are prepared and put into a culture well of the
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plate (c.f. 1.2). Plates for HTS can have either 24, 96, 384 wells, etc. i.e. multiples of
24. These wells will contain, depending on the type of experiment, culture medium
and depending on the layout/design, some chemical compounds. These wells will
also contain cell populations, and designed treatments are induced into them (YLL+11).
Upon completion of the wet-lab procedure, the plate is prepared for the further readout
during the image acquisition stage.
Figure 1.2: 96 wells plate for HTS.
(Alv)
1.2.3 Image acquisition
In biomedical laboratories images are usually acquired by measuring photon flux
in parallel, using a camera, or sequentially, using a point detector and equipment
that scans the area of interest. However, capturing an image from a camera into
the computer is straightforward, in most cases image acquisition needs to be tightly
synchronized with other computer-controllable equipment such as shutters, filter
wheels, x-y stages, z-axis focus drives and autofocus mechanisms; the controls for this
are implemented in software and hardware. This automation is necessary to gather
desired multiparametric information from a sample to allow the unattended acquisition
of large numbers of images in time-lapse series, z-stacks, multiple spatial locations
in a large sample or multiple samples in a large-scale experiment. Dedicated image
acquisition software is therefore indispensable to communicate with these various
components and coordinate their actions such that the hardware functions as quick and
flawless as possible as well as allowing the researcher to easily execute the following
sequence of acquisition events (EBG+12), i.e.:
1. Manual or automated acquisition.
2. Single time point or time series.
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3. Single focal plane or three-dimensional stack.
4. Single channel, multiple channels or hyperspectral.
5. Acquisition protocol is predefined or determined on the fly based on analysis of
image data.
Figure 1.3 shows four different microscopes commonly used in Hight-Throughput
Screening.
(a) Nikon 1 (b) Nikon 2
(c) Nikon 3 (d) BD Pathway
Figure 1.3: Microscopes for HTS.
(Tox)
1.2.4 Image analysis
Eliceiri et. al. (EBG+12) highlight the fact that biologists are increasingly interested in us-
ing image analysis to convert microscopy images into quantitative data (GM07) (LC09).
Image analysis, in particular, is a necessary step for experiments in which hundreds or
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thousands of images are collected by automated microscopy, whether for screening
multiple samples, collecting time or z-series data, or other technologies that generate
vast volumes of image data. In addition to image analysis in a high-throughput context,
image analysis is important for many biological studies: for example, quantifying the
amount and localization of a signaling protein, measuring changes in structures over
time, tracking invading cancer cells or looking at nonspatial data such as fluorescence-
lifetime data (Lak99). Image analysis facilitates data reduction and can help to ensure
that results are accurate, objective and reproducible.
For instance, during the image analysis process, raw images from the image acqui-
sition (c.f. 1.4(a)) stage are converted to auxiliary image results (c.f. 1.4(b) and 1.4(c)).
Quality enhancing filters and segmentation algorithms are executed to extract region of
interests (ROIs). Moreover, other types of processing based on ROIs such as object track-
ing are also applied. For each image sequence, phenotypic measurements are gathered
from ROIs and trajectories. Trajectories are not available for static images (YLL+11).
(a) Original image (b) Binary masks of (a) (c) Trajectories of (a)
Figure 1.4: Segmentation and subsequent image analysis
(YLL+11)
1.2.5 Data analysis
Eliceiri et. al. (EBG+12) conclude that the interpretation of the results from a high-
content imaging application requires proper presentation and visualization of the
image data. Many data display options are currently available according to the type of
microscope used. Image analysis results can be displayed graphically as heat maps,
line graphs, bar charts, dose response curves, or scatter plots e.g. (c.f. 1.5(a)) and 1.5(b)).
In addition, to interpret data within a plate or set of plates at a glance, thumbnail
images of the entire plate can also be displayed.
The purpose of data analysis varies from experiment to experiment. One basic
purpose is to identify “hits”, meaning to identify genes or compounds which play a
functional role in the cellular process that is under investigation (genes), or may posi-
tively or negatively affect the process (compounds). This is determined by comparing
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each sample with control treatments that are carried out under the same condition
but induce no change in the celullar process. Before “hits” are identified, quality
control and data normalization are performed to remove systematic errors and to allow
comparison and combination of samples from different plates (Di13).
(a) Cell migration (b) Structure dynamics
Figure 1.5: Data analysis
(YLL+11)
1.3 Data management in Cytomics
Finding “hits” contributes to identify targets for drugs. Drug discovery has a fundamen-
tal intrinsic dedication in increasing the number of novel medicines. However, in order
to accomplish this goal, high costs are involved from discovery through clinical trials
to approval (SKE07). Thus, the requirements for a more sophisticated IT infrastructure
used to assist the drug development process has been exponentially increased during
the last decade. Cytomics studies introduce information related to the behaviour of
the cell systems, exploiting this information is a key factor for the drug development
process. High-Throughput Screening (HTS) is one of the most common techniques
used in Cytomics. In HTS the image dataset size per plate is approximately between
20Gb to 40Gb and depending on the type of experiment performed multiple plates
can be used in one experiment and the number of images generated can reach around
100000 images per plate. The large volume of data generated in these experiments
make its management a challenge and a necessity.
The current data management challenges in Cytomics can be summarized as follow-
ing categories: (1) Heterogeneity of the data, (2) Data exploration, (3) Interoperability, (4)
Data sharing and reusability, (5) Understandability and (6) Transport of data. In the next
paragraphs we will discuss the categories.
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1.3.1 Heterogeneity of data
In HTS experiments the diversity of data is one of the main issues to be tackled for
the cytomics-based systems. The variety in the data is a consequence of the diversity
of harware and software components involved in HTS (c.f.1.6). A summary of these
components are:
Figure 1.6: Hardware and Software components in an HTS workflow
Types of microscope. In modern biology, one of the most basic tools is the visual
inspection of cells using a microscope and in modern optical microscopy for HTS is
commonly used the following types of microscope: (1) Confocal microscopes, (2) Mul-
tiphoton microscopes (3) Multispectral microscopes and (4) Fluorescence microscopes.
Each one managing different type of variables and parameters.
Image formats. The different types of microscopes have different file formats asso-
ciated with them. This means that metadata is sometimes only available in propietary
format. Consequently the image files generated will use a propietary format as well.
However, these propietary software also includes plugins or tools for exporting or
visualizing the images using more standarized format conventions e.g. tiff files.
Image and data analysis tools. There is a large number of open source tools and
inhouse applications developed for image and data analysis in HTS. Depending on the
programming language for the development and operating systems supported, it is
necessary to create additional scripts or import data for further processing according
to the file types supported by those tools. The output can also vary according to the
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analysis performed, for instance plain text files or binary data.
Spreadsheet applications. Spreadsheet applications are still very commonly used
by biologist in the HTS workflow for bookkeping metadata related to the design of
the experiment. The use of this type of applications have many drawbacks such
as: susceptible to errors, difficult to maintain, limited security and accesibility, not
shareable, and not suitable for querying.
Legacy systems. In the research groups, there are usually other systems which play
a role in the management of laboratory data or other repositories which store logistic
information of chemicals, compounds, or other components required in the lab. These
systems work most of the time independent of the HTS workflow but the information
contained needs to be synchronized with the experiment pipeline.
1.3.2 Data discovery
The drug discovery and development process depend on informed decision making.
A Cytomics platform needs to increase the quality and pertinence of information for
that decision-making process (SKE07). Therefore, identifying the location of mean-
ingful data in the large datasets generated in HTS experiments is the most important
challenge.
Figure 1.7: Data Lifecycle in a workflow
(DC08)
E-Science represents the increasing global collaborations of people and shared
resources that will be needed to solve the new problems in science and engineering.
These e-Science problems range from the simulation of whole engineering or biological
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systems, to research in bioinformatics, proteomics and pharmacogenetics (HT03). Hey
et. al. address the imminent flood of scientific data expected from the next generation
of experiments and the critical needs for analytical tools capable of exploiting and
automating the process of going from raw data to information to knowledge.
Deelman et. al. (DC08) present from the point of view of data, the lifecycle in a
workflow for e-Science expressed in four transformations. This includes the following
transformations (c.f. 1.7):
1. Data discovery.
2. Setting up the data processing pipeline.
3. Generation of derived data.
4. Archiving of derived data and its provenance.
Data analysis is often a collaborative process or is conducted within the context of a
scientific collaboration. Data discovery is highlighted due to the fact that scientists in
a collaboration frequently submit workflows to process datasets and derive scientific
knowledge. These collaborators may submit related workflows and build upon earlier
work by other scientists. Thus, scientists need to be able to discover information about
workflows that have been executed in the past, identify datasets of interest, and locate
analysis code and workflow templates.
1.3.3 Interoperability
Interoperability represents the posibility to exchange information between repositories.
Additionally, interoperability is a domain specific concept and the heterogeneity of
ICT implementations is such that there exist different solution spaces depending on
the combination of existing systems and in many cases such solutions are not directly
transferable to other cases (Kos06). According to Chen and Doumeingts (CDV08),
interoperability has the meaning of coexistence, and autonomy. If systems are interop-
erable, this mean that their components are connected by a communication network
and can interact; they can exchange services while continuing locally their own logics
of operation.
Each of the various types of data handled in the drug discovery process poses
its own specific problems for integration into the information systems and decision-
making processes (SKE07). The role of standards is thereby becoming crucial. Stan-
darization processes should be present in each stage of the scientific data lifecycle.
The development and wide adoption of common standards is extremely difficult
despite the fact that they represent the most effective tool to deal with interoperability.
In HTS, one of the main challenges is the standarization of the metadata i.e. naming
conventions in order to facilitate the validation, verification, exchange with external
platforms and the exploration of annotated information. Moreover, it is necessary to
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create standards to represent scientific data such as data models and standards for
query languages.
Developing comprehensive approaches is complex because data interoperability
is a problem that goes beyond technical aspects. Data interoperability approaches,
in order to be complete, should reconcile all the differences arising between data
providers and data consumers with respect to organizational, semantic, and technical
characteristics governing their “exchange” of data. The majority of existing solutions
focus on technical aspects only with very limited efforts and guidelines being oriented
to reconcile differences at the organizational level, probably because this domain
presents more complexities than others do (PCC13).
1.3.4 Understandability
In e-Science, the capability of the user to understand the information or knowledge
contained in the large repositories generated by each experiment is becoming a crit-
ical issue. An HTS dataset is very complex. Therefore there is a huge challenge in
organizing all this information so that it remains interpretable. With respect to the
mass of data produced, we do not believe that a solution is solely linking together
databases containing all the screening, laboratory testing, and chemical information.
The scientists whose collaborative work build the “road to the lead” need to efficiently
communicate. Only clear-cut analyses at each stage can optimize the process and
facilitate such communication (Hey02).
The approach proposed by Heyse et. al. (Hey02) consist of: (1) perform thorough
quality control to include only reliable data in further processing stages, (2) standardize,
process, condense, and annotate data at each stage as much as needed by the respective
experts involved, (3) keep data related to its context using metadata on assays, analyses,
and compounds, and (4) provide tools to analyze and interpret large datasets following
statistical and biophysical models and standard processes. This makes the overall
screening process transparent and traceable.
1.3.5 Data sharing and reusability
Demchenko et. al. (DGDLM13) emphasize that the emergence of computer aided
research methods is transforming the way how research is done and scientific data are
used. Four types of scientific data are defined:
• Raw data collected from observations and from experiments according to an
initial research method.
• Structured data and datasets that have gone through data filtering and processing.
• Published data that support one or another scientific hypothesis, research result
or statement.
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• Data linked to publications to support the wide research consolidation, integra-
tion and openness.
Collaboration is possible thanks to the contribution of new results as a consequence
of the validation performed by scientists after scientific data has been published. Col-
lecting information about the processes involved in the transformation of raw data to
published data becomes an extremely important aspect of scientific data management.
There is a close link between interoperability and collaboration. The interoperability
achieved by the use of standards for the metadata in HTS experiments, facilitates
the understandability, discoverability and thus promotes the collaboration among
scientists. Reseachers will be able to improve their contributions thanks to the use of
domain-specific metadata information standards.
Reusability of published data within the scientific community is still another aspect
to take into consideration. Understandability of the semantics of published data is a
key factor for reusability and this has been done manually. However, given the volume
of the data, this becomes, so far, impractical in the scale of Big Data science.
1.3.6 Transport of data
Kaisler et. al. (KAEM13) describe the storage and transport issues for big data. Current
disk technology limits are about 4 terabytes per disk. So, 1 exabyte would require 25,000
disks. Even if an exabyte of data could be processed on a single computer system, the
current systems do not allow to directly attach the requisite number of disks. Access
to those data would overwhelm current communication networks. Assuming that a
1 gigabyte per second network has an effective sustainable transfer rate of 80%, the
sustainable bandwidth is about 100 megabytes. Thus, transferring an exabyte would
take about 116 days, if we assume that a sustained transfer could be maintained. It
would take longer to transmit the data from a collection or storage point to a processing
point than it would to actually process it.
Two solutions manifest themselves. First, process the data “in place” and transmit
only the resulting information. In other words, “bring the code to the data", vs. the
traditional method of “bring the data to the code." Second, perform triage on the data
and transmit only that data which is critical to the downstream analysis. In either case,
integrity and provenance metadata should be transmitted along with the actual data,
this will ensure traceability and validation of the data before the processing stage.
Cytomics based platforms must take special care to the six categories of the current
data management challenges in Cytomics in order to facilitate the interaction of re-
searchers with their data. This means that platforms should ensure that research data
is FAIR (Findable, Accessible, Interoperable and Reusable).
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1.4 LIM Systems
A typical approach to the management of large volume of data in a laboratory is a
Laboratory Information Management System (LIMS). LIMS is a computer application
designed for the analytical laboratory that is designed to administer samples, acquire
and manipulate data, and report results via a database. It automates the process of
sampling, analysis and reporting (Mah91) (DAJ12).
A more complete definition is provided by Skobelev et. al. (SZK+11), Laboratory
information management systems belong to the class of application software intended
for storage and management of information obtained in the course of the work of
the laboratory. The systems are used to control and manage samples, standards, test
results, reports, laboratory staff, instruments, and work flow automation. Integration of
laboratory information management systems with the enterprise’s information systems
will make it possible to promptly transmit required data to the laboratory and the
enterprise administration.
High-throughput screening (HTS) due to the overwhelming amounts of data is
pushing forward the need for sophisticated IT infrastructure in order to enhance the
laboratory performance. LIM systems have been designed as a first step to face this
dilemma. However, the continuous progress in tools, hardware, and heterogeneity of
the components involved in HTS make still difficult to completely tackle this problem.
Under the term Laboratory Information Management System, industry-related IT
solutions for research, development, service, and production in the fields of chemistry,
biology, environmental protection, or medicine are combined. The interdisciplinary
object of the life sciences meanwhile characterizes a broad, large class of laboratory
information management systems and offers a potential for new general system con-
cepts in laboratory automation before the background of innovative Internet technolo-
gies (TGDS04) (AMF00).
Figure 1.9 (DAJ12) describes how LIMS assist laboratories in tracking and managing
its information resources, particularly the data that represents the laboratory product.
LIMS has contributed in improving the administration of labs data from the perpec-
tive of a production environment. However, with respect to the research environment,
LIMS has limitations such as: (1) dealing with unstructured data, (2) ensure interop-
erability between components in an HTS environment, (3) facilitate experiment data
sharing and (4) promote reusability.
1.4.1 LIMS environment
A LIMS is more complex than just a single application and it is better to consider the
term environment to specify the set of elements who interact within a laboratory. These
elements are shown in Figure 1.8 (DAJ12), i.e:
1. LIMS application.
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Figure 1.8: Diagram of a tyical LIMS environment
(DAJ12)
2. Data Analysis tools interfaced directly with the LIMS.
3. Legacy systems and computer systems interfaced with the LIMS.
4. Applications external to the laboratory that are also interfaced to the LIMS e.g.
an enterprise resource planning system.
1.4.2 How a typical LIMS works
The LIMS is in charge of the analysis and distribution of the data generated in the
laboratory. It becomes the single point of interaction between the data and the different
tools and systems used in the laboratory. The data is stored in a single repository and
this allows to centralize its flow and access through the organization (DAJ12).
Once the sample is logged into the LIMS package, it automatically takes over the
further operations and generates the work sheet/protocol sheet/analytical work record.
The workflow contains all the diagnostics required to be carried out for the sample
(Figure 1.9).
While carrying out the actual testing, the readings and observations are noted
down in the workflow. After completing the diagnostics all data are fed into the
LIMS package. It automatically calculates the results, compares the findings with the
standards, and also decides about the compliance with the standards. After this it
prints out the certificate of analysis in the prescribed format that is already fed into the
software.
It is the LIMS that decides about the conformance and non-conformance of the
sample with the standard and not the analyst. The technician just has to enter the
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required inputs (readings/observations); the desired output format can be selected,
and results can be generated in desired options without giving any external formulae
for calculation (KGG10).
Figure 1.9: Sample work flow diagram
(DAJ12)
1.4.3 Benefits of LIMS
A LIMS provides benefits for many of the users of a laboratory. However, a LIMS does
represent an expense that must be considered. This expense will almost certainly have
to be justified by a level of higher management. The following is a brief outline of
several of the main benefits identified and realized from current users of LIMS (DAJ12).
1. Information can be obtained with the click of a button rather than having to dig
through files.
2. Years of data can be kept easily without the need for traditional archiving.
3. The improvement of business efficiency.
4. Improvement of data quality (all the instruments are integrated).
5. Automated log-in, tracking, and management.
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6. Automated customer reports (Turnaround Time, Work Load).
7. Automated Integration of Hand-held LIMS devices.
8. Automated Quality Control.
9. Daily Quality Reports.
10. Easily accessible data via the web.
LIMS is a useful tool to manage structured information produced in the laboratory.
However, an HTS environment is constantly changing due to the diversity of tech-
nologies involved which produce continuosly more volume of data. Current datasets
generated in HTS are commonly unstructured and not suitable for being stored in a
rigid database system. The need to align research data to the FAIR paradigm force
the urgent need to design new software architectures which are able to integrate the
benefits of LIMS with platforms capable to manage unstructured data in Cytomics.
1.5 Thesis structure
This thesis consists of six chapters: (1) Introduction, (2) CytomicsDB architecture, (3)
Metadata management, (4) Metadata Validation, (5) Cluster Integration and (6) Conclusion
and Discussion.
Chapter 1 introduces the scope of thesis as well as its background. In addition,
here we review the existing challenges in the management of large volumes of data in
Cytomics. Thereafter, the lab management systems that currently manage lab data and
their issues for dealing with high-throughput data is briefly described. Moreover, the
typical workflow in High-Throughput Screening (HTS) experiments is presented.
Chapter 2 describes our research in developing CytomicsDB, a modern RDBMS
based platform, designed to provide an architecture capable of dealing with the com-
putational requirements involved in high-throughput content.
Chapter 3 introduces a semantic approach for organizing the metadata involved in
High-Throughput Screening experiments. The main goal is to facilitate the exploration
process in the HTS workflow, scientists are aware of semantics and they are pushing
forward the need for new approaches in organizing the metadata according to which
queries are mostly applied on the scientific data.
Chapter 4 provides a semantic-based metadata validation approach applied in
CytomicsDB. The objective is to ensure the integrity, consistency and reliability of the
data stored in the platform. This is a critical requirement for image and data analysis
and further data exploration of the experiment‘s results.
Chapter 5 discusses how the integration with a computational cluster to Cy-
tomicsDB architecture can speed up the image analysis stage in the workflow of
an HTS experiments.
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In this chapter, we propose a platform for managing and analyzing HTS images resulting
from cytomics screens taking the automated HTS workflow as a starting point. This platform
seamlessly integrates the whole HTS workflow into a single system. The platform relies
on a modern relational database system to store user data and process user requests, while
providing a convenient web interface to end-users. By implementing this platform, the overall
workload of HTS experiments, from experiment design to data analysis, is reduced significantly.
Additionally, the platform provides the potential for data integration to accomplish genotype-to-
phenotype modeling studies.
This chapter is based on the following publications:
• K. Yan, E. Larios, S. LeDévédec, B. van de Water and F. J. Verbeek. Automa-
tion in cytomics: Systematic solution for image analysis and management
in high throughput sequences. In Proceedings IEEE Conf. Engineering and
Technology (CET 2011), volume 7, pages 195–198. 2011.
• E. Larios, Y. Zhang, K. Yan, Z. Di, S. LeDévédec, F. Groffen, and F.J. Verbeek.
Automation in cytomics: A modern rdbms based platform for image anal-
ysis and management in high-throughput screening experiments. In Pro-




Recent developments in microscopy technology allows various cell and structure phe-
notypes to be visualized using genetic engineering. With a time-lapse image-acquisition
approach, dynamic activities such as cell migration can be captured and analyzed.
When performed in large-scale via robotics, such approach is often referred to as a
High-Throughput Screening (HTS). At the work floor this is often called “screen”. In
cytometry, HTS experiments, at both cellular and structural level, are widely employed
in functional analysis of chemical compounds, antibodies and genes. With automated
image analysis, a quantification of cell activity can be extracted from HTS experiments.
In this manner, biological hypothesis or diagnostic testing can be verified via machine
learning using the results from the image analysis. HTS experiments, supported by
automated image analysis and data analysis, can depict an objective understanding of
the cell response to various treatments or exposures.
In this chapter, we set our scope to the bioinformatics aspects of HTS. An HTS
experiment starts with the design of a culture plate layout containing N ×M wells in
which the cells are kept, cultured and to which experimental conditions are applied.
The response of the cells is then recorded through time-lapse (microscopy) imaging
and the resulting time-lapse image sequence is the basis for the image analysis. The
design of the plate layout is a repository of the experiment as a whole. From a study of
the workflow of biologists, we have established an HTS workflow system.
Currently, spreadsheet applications are commonly used for bookkeeping the infor-
mation generated during the workflow of HTS experiments. This approach has many
drawbacks. It usually takes months to finish a complete experiment, i.e., from the plate
design to the data analysis. Furthermore, images produced by the HTS experiments
are not linked properly with their metadata and the analysis results. This scenario
makes it difficult to do a proper knowledge discovery. So, most of the process within
the workflow of HTS experiments are developed manually, which is highly prone to
man made errors. Moreover, spreadsheets often differ in format and are not stored in a
central place. This makes it hard for scientists from even the same institute to search,
let alone to disclose their results in a uniform and efficient way.
To eventually tackle all these issues, we propose an HTS platform for managing and
analysing cytomic images produced by HTS experiments. The platform seamlessly
integrates the whole HTS workflow into a single system and provides end-users
a convenient GUI to interact with the system. The platform consists of a layered
architecture. First, an end-user layer that is responsible for the interaction with the
scientists who perform different HTS experiments in cytomics. Then, the middleware
layer that is responsible of the management of secure and reliable communication
among the different components in the platform. Finally, a database-computational
layer, in charge of the repository and execution of the image and data analysis.
Preliminary tests show that by using this platform, the overall workload of HTS
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experiments, from experiment design to data analysis, is reduced significantly. This
is because, among others, in the HTS platform, the design of plate layout is done
automatically. Using spreadsheets, it takes an experienced biologist one week to
manually finish the mapping of 400-600 gene targets, while it takes less than a day to
use the plate design module in the HTS system. It also enables queries over datasets of
multiple experiments. Thus, automation in cytomics provides a robust environment
for HTS experiments. To sum up, the contributions of this work include:
1. Establishing a workflow system of the HTS experiments (Section 2.2).
2. An integrated platform to automate data management and image analysis of
cytomic HTS experiments (Section 2.3).
3. The design of the database to store (almost) all data produced and used in the
HTS experiments (Section 2.4).
Finally, we discuss related work in Section 2.5 and conclude in Section 2.6.
Figure 2.1: Automated workflow of an HTS Experiment
2.2 Automated Workflow of the HTS experiments
An automated workflow of a general HTS experiment is shown in Figure 2.1, where the
typical stages are depicted separately. In this chapter, we describe the four functional
modules in this HTS workflow: (1) plate design, (2) image analysis, (3) data management,
and (4) pattern recognition (YLL+11).
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2.2.1 Plate Layout Design Module
The design of a plate is considered as the cornerstone for an HTS experiment. Therefore,
we have developed a Graphical User Interface (GUI) in our HTS platform to construct
the layout for a plate (see Figure 2.2). The GUI allows end-users to rapidly deploy,
modify and search through plate designs, to which auxiliary data such as experimental
protocols, images, analysis result and supplementary literature is attached. In addition,
the plate design provides a fast cross-reference mechanism in comparing data from
various origins. This module is also used as the front end for the visualisation of results
such as using heat maps, cell detection or motion trajectories.
Figure 2.2: Web plate layout design GUI
2.2.2 Image Analysis Module
In the acquisition phase, the time-lapse sequences are connected to the plate design.
Customized image processing and analysis tools or algorithms are applied on the raw
images to obtain features for each of the different treatments. Our image analysis
kernel is deployed to provide a customised and robust image segmentation and object
tracking algorithm (YVDvdW09), dedicated to various types of cytometry. The current
package covers solutions to cell migration, cellular matrix dynamics and structure
dynamics analysis (see Figures 2.3, 2.4, 2.5). The package has been practised in HTS
experiments for toxic compound screening of cancer metastasis (LYdB+10) (QSY+11),
wound-and-recovery of kidney cells (QSY+11) and cell matrix adhesion complex sig-
naling, etc (CYW+11).
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Pseudo Code 1: Watershed Masked Clustering Algorithm 
Perform maxima-seeded watershed segmentation 
Reverse watershed line into coarse region 
    for each coarse region r do 
        Perform weighted fuzzy C-mean clustering in intensity     
space I of r 
        Obtain labeling 
        Create regional mask 
        end for 
Combine regional mask into final object label 
 
 
(a) Image is divided into several coarse regions 
 
(b) The intensity histogram of the 
whole image 
 
(c) The intensity histogram of one 
random coarse region 
Figure 4. Image and coarse regions 
The tracking of objects is accomplished by a customized 
algorithms deployed in the image analysis package. The 
fundamental principle behind this tracking algorithm is to 
estimate the minimum mean shift vector based on given model 
[1][3]. 
 
(a) Cell tracking results 
 
(b) Adhesion tacking results 
Figure 5. Using our image analysis solution, the phenotypic measurements of 
(a) live cells and (b) adhesion can be extracted. 
With the binary masks and trajectories information 
obtained from image analysis, several phenotypic 
measurements are extracted for each object. Using state-of-art 
pattern recognition and statistical analysis, the effect of 
chemical compound can be easily quantified and compared (cf. 
Fig. 6). Depending on experiment setting, our package may 
employ up to 31 phenotypic measurements during the analysis. 
 
Figure 6. Phenotypic characterization of the epidermal growth factor (EGF) 
treatment using a highly aggressive cancer cell line, the illustrated features are 
picked by branch-&-bound feature selection. The EGF-treated cell group 
shows a significant increased migration velocity while the extension 
This module is designed as web service API. As the image 
analysis computation requires large image volumes to be 
processed, GRID computing is used to obtain results in 
reasonable time. 
C. Image Data Management System 
In cytomics, the amount of image data can easily exceed 
the terabyte-scale. The organization and storage of large 
volume data is therefore nontrivial. The accessibility of large 
volume image data already poses an obstacle in the current 
stage. Unlike other high-content data type such as video 
streams, bio-image data require a complete error-free quality 
during transportation. Uncorrected errors are potentially 
catastrophic as consequences may be accumulated into 
subsequent stages. In a multiuser environment, the data flow 
also faces a high-concurrency environment. The database 
becomes a bottleneck that must handle high concurrency 
because of the large number of images that are used in the 
analysis phase.  
The platform uses an XML supported database (Oracle) to 
store all the information related to the metadata of the 
experiments, measurements and analysis results. This 
information is hierarchically organized in the XML format, 
which facilitates the integration with other legacy systems such 
as the Image Analysis API, Cyttron API [5], File Servers, etc. 
The platform provides access to the data stored through web 
services which use XQuery to retrieve particular information 
requested by the End-user GUI.  
 
Figure 2.3: age and coa se regions
(CYW+11)
Pseudo Code 1: Watershed Masked Clustering Algorithm 
Perfo m maxima-seeded watershed segmentation 
Reverse watershed line into coarse region 
    for each coarse region r do 
        Perform weighted fuzzy C-mean clustering in intensity     
space I of r 
        Obtain labeling 
        Create regional mask 
        end for 
Combine regional mask into final object label 
 
 
(a) Image is divided into several coarse regions 
 
(b) The intensity histogram of the 
whole image 
 
(c) The intensity histogram of one 
random coarse region 
Figure 4. Image and coarse regions 
The tracking of objects is accomplished by a customized 
algorithms deployed in the image analysis package. The 
fundamental principle behind this tracking algorithm is to 
estimate the minimum mean shift vector based on given model 
[1][3]. 
 
(a) Cell tracking results 
 
(b) Adhesion tacking results 
Figure 5. Using our image analysis solution, the phenotypic measurements of 
(a) live cells and (b) adhesion can be extracted. 
With the binary masks and trajectories information 
obtained from image analysis, several phenotypic 
measurements are extracted for each object. Using state-of-art 
pattern recognition and statistical analysis, the effect of 
chemical compound can be easily quantified and compared (cf. 
Fig. 6). Depending on experiment setting, our package may 
employ up to 31 phenotypic measurements during the analysis. 
 
Figure 6. Phenotypic characterization of the epidermal growth factor (EGF) 
treatment using a highly aggressive cancer cell line, the illustrated features are 
picked by branch-&-bound feature selection. The EGF-treated cell group 
shows a significant increased migration velocity while the extension 
This module is designed as web service API. As the image 
analysis computation requires large image volumes to be 
processed, GRID computing is used to obtain results in 
reasonable time. 
C. Image Data Management System 
In cytomics, the amount of image data can easily exceed 
the terabyte-scale. The organization and storage of large 
volume data is therefore nontrivial. The accessibility of large 
volume image data already poses an obstacle in the current 
stage. Unlike other high-content data type such as video 
streams, bio-image data require a complete error-free quality 
during transportation. Uncorrected errors are potentially 
catastrophic as consequences may be accumulated into 
subsequent stages. In a multiuser environment, the data flow 
also faces a high-concurrency environment. The database 
becomes a bottleneck that must handle high concurrency 
because of the large number of images that are used in the 
analysis phase.  
The platform uses an XML supported database (Oracle) to 
store all the information related to the metadata of the 
experiments, measurements and analysis results. This 
information is hierarchically organized in the XML format, 
which facilitates the integration with other legacy systems such 
as the Image Analysis API, Cyttron API [5], File Servers, etc. 
The platform provides access to the data stored through web 
services which use XQuery to retrieve particular information 
requested by the End-user GUI.  
 
Figure 2.4: Using our image a alysis solution, the phenotypic measurements of (a) live cells
and (b) adhesion can be extracted
(CYW+11)
The segmentation of objects is conducted using our watershed masked clustering
algorithm, an innovative algorithm dedicated to fluorescence microscopy imaging. Fre-
quently, the efficiency of fluorescence staining or protein fusion is subjective and highly
unpredictable, which results in disorganized intensity bias within and between cells
(see Figure 2.3(a)). The principle behind the algorithm is to divide such an extreme
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Figure 2.5: Phenotypic characterization of the Epidermal Growth Factor (EGF) treatment
using a highly aggressive cancer cell line, the illustrated features are picked by
branch-and-bound feature selection. The EGF-treated cell group shows a significant
increased migration velocity
(CYW+11)
and multimodal optimization problem (Figure 2.3(b)) into several sub-optimal yet
uni-modal optimization problems (Figure 2.3(c)). Such divided-and-conquer strategy
provides an extended flexibility in searching intensity thresholds in each image. Con-
trary to bottom-up segmentation strategies such as the Otsu algorithm, our solution
prevents undertraining by introducing a flexible kernel definition based on the con-
genital (intensity) homogeneity of an image. Unlike top-down segmentation strategies
such as the level-set algorithm, our current algorithm prevents overtraining by a global
overview of the intensity distribution of the region, therefore, it is less sensitive to local
intensity distortion; in addition, our algorithm does not require any prior knowledge
or manual interference during segmentation while it is mandatory for most existing
top-down methods.
The tracking of objects is accomplished by customised algorithms deployed in the
image analysis package. The principle behind this tracking algorithm is to estimate the
minimum mean shift vector based on a given model (LYdB+10) (YVDvdW09).
With the binary masks and trajectories information obtained from image analysis,
several phenotypic measurements are extracted for each object. Using the state-of-art
pattern recognition and statistical analysis techniques, the effect of chemical com-
pounds can be easily quantified and compared (Figure 2.5). Depending on the experi-
ment setting, our package may employ up to 31 phenotypic measurements during the
analysis.
The image analysis module is designed as a web service API module in the HTS
platform. As the image analysis computation requires large image volumes to be
processed, a high performance scientific cluster performs the image processing in order
to obtain results in reasonable time.
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2.2.3 Data Management Module
In cytomics bookkeeping of the information generated during lab experiments is
crucial and the amount of image data can easily exceed the terabyte-scale. However,
currently spreadsheets applications are commonly used for storing experiment data.
The accessibility of large volume of image data already poses an obstacle in the current
stage.
After scientists, having performed HTS experiments, it is necessary to store meta
information, including the experiment type, the protocol followed, experimental condi-
tions used and the plate design, and associate each well in the plate to the raw images
generated during the experiments and the results obtained from the image and data
analysis when these processes are completed.
Currently, the large volume of images are stored in a file server and they are accessed
following a standard naming convention. The locations of the files are stored in the
spreadsheet application used for the experiment, but this is not a practical solution for
knowledge discovery later on or querying the results obtained in the analysis process.
The platform uses MonetDB, a modern column-based database management system
(DBMS) as a repository of the experiments metadata that is used in the HTS Workflow
System. Each component of the architecture communicate with the database through
web services. This makes the future integration with other APIs more flexible.
2.2.4 Data and Pattern Analysis Module
Typical to the kind of analysis required for cytomics data is that the temporal as
well as the spatial dimension is included in the analysis. The spatial dimension
tells us where a cell or cell structure is, whereas the time-point informs us when
it is at that particular location. Features are derived from the images that are time
lapse series (2D+T or 3D+T). Over these features pattern recognition procedures are
multi-parametric analysis. It is a basic form of machine learning solution, which
is frequently employed in the decision-making procedure of biological and medical
research. A certain pattern recognition procedure may be engaged in supporting
various conclusions. For example, a clustering operation based on cell morphological
measurements may provide an innate subpopulation within a cell culture (LYdB+10)
while a classification operation using temporal phenotypic profile can be used to
identify of each cell phase during division (NWH+10). The service that deals with the
pattern recognition is based on the PR-Tools software package developed at the Delft
University of Technology (www.prtools.org).
The PR-Tools library can be integrated in MatLab (MAT10) and we have used
it in that fashion. In order to deal with the temporal dimension, the package was
extended with specific elements to allow temporal analysis over spatial data (Yan13).
The prototype data analysis module is implemented as a web service API based on
output generated by MatLab deployment tools. The availability of MatLab with PR-
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Tools within this architecture allows for rapid prototyping with a range of complex
mathematical algorithms. In addition, PR-Tools in MatLab has its own GUI and in
this manner data mining strategies can be explored by the end-user without in-depth
knowledge of machine learning. The flexibility that is accomplished in this manner is
efficient for the end-users as well as the software engineers who need to maintain and
implement the services for machine learning.
2.3 System Architecture of the HTS Analysis Platform
Figure 2.6: The HTS analysis platform architecture
To automate the workflow of HTS experiments and provide the users with a
convenient interface to interact with the system, we have designed an HTS analysis
platform (YLL+11) (for short: HTS platform), which has a layered architecture. Figure 2.6
depicts the components in each layer of the architecture.
2.3.1 The Presentation Layer
The HTS platform enables end-users to carry out complete HTS experiments using
a single graphical user interface, i.e., the HTS Analysis GUI. This way, even for end-
users without extensive knowledge in cytomics, it is easy to learn how to analyse HTS
experiments in cytometry. In addition, data sets produced under different conditions
or from different HTS experiments are available through one interface. This also counts
for the resulting data from each step in an HTS experiment. As a result, end-users can
easily view, compare and analyse the different data sets.
2.3.2 The Service Layer
The service layer, through web services, support every step in the HTS workflow that
is done on the computers. The APIs are grouped in three modules in the Web Service
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API layer, with each module corresponding to a module described in Section 2.2. This
module structure allows quick development, error isolation and easy extending with
more functional modules in the future.
We chose SOAP (Simple Object Access Protocol) messages for invoking the web
services and receiving results, because of its approved interoperability in web applica-
tions and heterogeneous environments. In case of the HTS platform, because of the
presence of legacy systems we must support different programming languages. Using
SOAP makes it possible for various languages to invoke operations from each other.
Transportation of the data generated by an experiment is integrated into web service
calls. Large files are transmitted as attachments of the SOAP messages. To do this, the
MTOM (Message Transmission Optimization Mechanism) feature (GMNR05) of the
Glassfish Server is used. Ensuring error free data transmission and controlling user
access permissions are done at the application level.
2.3.3 The Persistence Layer
The persistence layer is based on the principle of object-relational mapping (ORM)
which involves delegating access to a relational database and, which in turn gives an
object-oriented view of the relational data, and vice versa (O’N). The Java Persistence
API (JPA) framework has been implemented in this layer to keep a bidirectional
correspondence between the database and objects. Those Java objects used in this
framework are known as Java Entities (KS06). The entities are objects that live shortly
in memory but persistently in the database. Besides that, they have all the features
of a Java class like instantiation, abstraction, inheritance, relationships and so on.
The entities used in CytomicsDB follow the same structure as the tables they map
to. CRUD operations are registered as named query methods which are written in
Java Persistence Query Language (JPQL). These customized queries can be attached to
entities as native queries via JPA.
2.3.4 The Repository Layer
There are two components in this layer. For the data management component, we
made a conscious choice for MonetDB (www.monetdb.org), a modern column-based
database system, after having considered different alternatives. For instance, in the
initial design of the database schema, we have considered to use an XML supporting
DBMS such as Oracle or Microsoft SQL Server in order to facilitate a flexible integration
with other systems in the future. However, it is generally known that, compared with
relational data, XML data requires considerable storage overhead and processing time,
which makes it unsuitable as a storage format for the large volume of cytomic data.
Moreover, traditional database systems are optimised for transactional queries, while
in cytomics, we mainly have analytical queries. Traditional database systems generally
carry too much overhead when processing analytical queries (Bon02). What we need is
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a database optimised for data mining applications. MonetDB is a leading open source
database system that has been designed specially for such applications (Bon02). It has
been well-known for its performance in processing analytical queries on large scale
data (BMK09). Thus, in our final decision, we use SOAP messages (i.e., XML format) to
exchange small sized (meta-)data, but use MonetDB to store a major portion of the data
produced and used during the HTS experiments, including all metadata generated
during analysis. Additionally, a powerful scientific computer cluster is used to execute
computing intensive image analysis tools. The future plan is to move also the raw data
and as much as possible operations on them into the database system.
Figure 2.7: Flow of control of the HTS platform
2.3.5 Flow of Control
The diagram shown in Figure 2.7 illustrates the flows of the control in the HTS platform.
How the main features of the platform are executed is shown by five sequences of
annotated arrows starting from the end-user GUI. Arrows handling the same operation
are grouped together by a major number, while the minor numbers corresponds to the
order of a particular step that is called in its containing sequence. Below we describe
each sequence.
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Sequence 1 handles a new plate design, which is straightforward: the request is
sent to MonetDB and a new entry is created. Sequence 2 handles uploading an HTS
image request. Because currently the raw image data is stored separately, this request
results in the metadata being stored in MonetDB while the binary data is stored on
the file server. Sequence 3 handles an image analysis request, which is passed to
the scientific super computer, since the tools for the analysis stage are there. Then
the results are sent to MonetDB and stored there (step 3.3). Sequence 4 handles a
data analysis request, which is first sent to MonetDB. Then, MonetDB passes both the
request and the necessary data (obtained from the image analysis) to the scientific
super computer for execution. The results are again stored in MonetDB. Since the most
used data is stored at one place, in sequence 5, a view results request can be handled
by just requesting data of both image analysis and data analysis from MonetDB. In
the GUI, the results are displayed with the corresponding plate layout, as indicated in
Figure 2.2.
Summary. In this section, we described the software architecture of the HTS platform,
how its main features are processed, and how web services are used for the communi-
cation with the DBMS and the dedicated scientific computer cloud. In the next section,
we present how all data is stored in the DBMS.
2.4 Database Design
Figure 2.8: Database schema for Project Metadata
The complete relational database schema designed to store the metadata, location
of images and binary data generated during the execution of the HTS workflow is
shown in Figure 2.8, Figure 2.9, Figure 2.10, and Figure 2.11. The database schema
can be roughly divided into five views: i) users and the experiment sets they work on
(c.f. 2.8, c.f. 2.9), ii) the design of the culture plates (c.f. 2.10), iii) raw images acquired
during a single HTS experiment (c.f. 2.11), iv) results of image analysis (c.f. 2.11), and
v) results of data analysis (c.f. 2.11). In order to simplify the views, the tables show
only the primary and foreign keys. Below we explain how the data is stored in each of
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Figure 2.9: Database schema for Experiment Metadata
Figure 2.10: Database schema for Plate-Well Metadata
these views and the relationships among the tables.
2.4.1 Users and Experiment Sets
The basic information of a user is stored in the table hts_user. A user belongs to a
hts_group (research group) and has a special privilege for accessing the platform ac-
cording to role_platform, possible values are: system administrator, administrator
and regular user. Additionally, every user can start with a new Experiment, and is
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Figure 2.11: Database schema for Raw Images and Measurement Metadata
then also the author of this set of experiments.
Multiple users may work on the same experiment set, but only the author of an ex-
periment set can grant another user the access to this set. The table User_experiment
stores the data required for validating the access control of all users. Possible values of
Role_experiment include: author, expert user, analyst user and guest user.
2.4.2 Plates and Wells
An HTS experiment starts with the design of the layout of a culture Plate of N ×M
Wells in which the cells are kept and cultured. An experiment set can contain multiple
culture plates, which typically have sizes of (but not restricted to) 4 × 6, 6 × 8, 8 × 12
or 16 × 24 wells. A user can create conditions e.g. cell_lines, compounds, siRNA,
coating, etc. to be applied to the wells. Similar to the Experiment table, restricted
access to the conditions are denoted explicitly according to the privilege granted
to the user in table Role_platform. Table Well keeps track of which conditions are
used by them in each experiment. Thus, one condition can be used in multiple exper-
iment sets and accessed by multiple users. However, by referring to the compound
primary key (User_id, Expe_id) of User_experiment, a user is restricted to
only have access to a condition, if he/she has access to an experiment set using the
condition. Additionally, because conditions are applied on individual wells, the table
Well_(condition) is designed to store this information.
2.4.3 Raw Images
A third step in the HTS workflow (the “HTS” step in Figure 2.1) is to process the
cultured plates using automated microscopy imaging system. The response of the cells
is recorded through time-lapse microscopy imaging and the resulting image sequences
are the basis for the image analysis. The structure of an image file depends on the type
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of experiment (denoted by Type_id in Experiment) and the microscopy used in the
experiment. Currently, four types of structures are supported:
1. 2D (XY): this structure corresponds to one frame containing one image which is
composed of multiple channels ([1]Frame → [1]Image → [1..n]Channels).
2. 2D+T (XY+T): this structure corresponds to one video with multiple frames.
Each frame contains one image composed of multiple channels ([1]Video →
[1..n]Frame → [1]Image → [1..n]Channels).
3. 3D (XYZ): this structure corresponds to one frame with multiple sections. Each
section contains one image composed of multiple channels ([1]Frame→ [1..n]Sections
→ [1]Image → [1..n]Channels).
4. 3D+T (XYZ+T): this structure corresponds to one video with multiple frames.
Each frame can have multiple sections and each section contains one image
composed of multiple channels ([1]Video → [1..n]Frame → [1..n]Sections →
[1]Image → [1..n]Channels).
These four structures can be represented by the most general one, i.e., 3D+T. The
2D structure can be seen as a video of one frame containing one section. Each frame in
the 2D+T structure can be regarded to contain one section. Finally, the 3D structure
can be seen as a video of one frame. In the database schema, the generalised structures
are captured by five relations, i.e., Video, Frame, Section, Image and Channel,
connected to each other using foreign keys. Information stored in these relations is
similar, namely a name and a description. Only the main table Video contains some
extra information, e.g., a foreign key referring to the table Well to denote from which
well the image has been acquired. Because currently only the metadata of the raw
images are stored in these tables, the location of the image binary data is stored in
Vide_url. The exact type of the video structure can be looked up using Type_id in
the Experiment.
2.4.4 Results of Image Analysis
The results of image analysis are auxiliary images which, currently, are binary masks
or trajectories. These images are result of the execution of quality enhancing filters and
segmentation algorithms employed to extract region of interests (ROIs). The metadata
of these images is stored in the table Measurement, including the location where the
binary data is stored. Moreover, this table also store the phenotypic measurements
gathered from ROIs and location of auxiliary images e.g. trajectories. The foreign key
Vide_id links a measurement record to the raw video image file, on which the image
analysis has been applied.
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2.4.5 Results of Data Analysis
The goal of the data analysis stage is converting image data into comprehensive conclu-
sions. For achieving this goal basic operations such as feature selection, clustering and
classification are applied to the measurements extracted from the image analysis. The
parameters used by the operation and the extracted features are respectively stored in
Feature, and are connected to the corresponding Measurement record via foreign
keys.
2.5 Related Work
Data management in microscopy and cytometry has been acknowledged as an impor-
tant issue. Systems have been developed to manage these resources, to this respect
the Open Microscopy Environment (www.openmicroscopy.org) and the OMERO
platform is a good example. Another approach is connecting all kinds of imaging data
and creating a kind of virtual microscope; such has been elaborated in the Cyttron
project (KBK+09) (www.cyttron.org). The connection is realized by the use of on-
tologies. Both projects strive at adding value to the data and allow to process the data
with plug-in like packages. These approaches are very suitable for the usage of web
services. Both projects are also very generic in their architecture and not particularly
fit for HTS and the volume of data that is produced. Important for data management
in cytometry is that both metadata and bulk data are accommodated well. The accu-
mulation of metadata is crucial; successful accommodation of both metadata and bulk
data has been applied in the field of microarrays (SMS+02). Here, the interplay of the
vendor of scanning equipment with the world of researchers in the life-sciences has
delivered a standard that is proving its use in research. One cannot, one to one, copy
the data model that has been applied in the field of microarrays. Like in cytometry, for
microarrays the starting point is images in multiple channels. However, for cytometry,
location and time components are features that are derived from the images whereas in
microarrays the images are static from a template that is provided by the manufacturer.
In cytometry there is a large volume of data that needs to be processed but this volume
is determined by the experiment and it can be different each time; i.e. it depends very
much from the experimental setup. This requires a very flexible approach to the model
of the data. An important requirement for the metadata is that they can be used to
link to other datasets. The use of curated concepts for annotation is part of the MAGE
concept and is also embedded in the CytomicsDB project. We have successfully applied
such approach for the zebrafish in which the precise annotations in the metadata were
used to link out to other databases (BV08) and similarly, as mentioned, in the Cyttron
projects the annotations are used to make direct connections within the data (KBK+09).
For cytometry data linking to other data is important in terms of interoperability so that
other datasets, i.e. images, can be directly involved in an analysis. For cytometry, there
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are processing environments that are very much geared towards the volume of data
that is commonly processed in HTS. The Konstanz Information Miner (KNIME) is a
good example of such environment. It offers good functionality to process the data but
it does not directly map to the workflow that is common in HTS and it does not support
elaborate image analysis. Therefore, in order to be flexible, the workflow is directed
towards standard packages for data processing and the processes are separated in
different services rather than one service dealing with all processing. So, one service
specifically for the image processing and analysis (e.g. ImageJ or DIPLIB) and another
service for the pattern recognition and machine learning (e.g. WEKA or PRTools). In
this manner flexibility is accomplished on the services that one can use.
2.6 Conclusions and Future work
In this chapter we presented the design of a platform for high content data analysis in
the High-Throughput Screen cytomic experiments that seamlessly connects with the
workflow of the biologists and for which all processes are automated. Based on the beta
testing, this system increases the efficiency of post-experiment analysis by 400%. That
is, by using this the framework, it now takes less than a week to accomplish the data
analysis that previously easily took more than a month with commercial software, or a
year by manual observation. Comparing with solutions such as CellProfiler (CJL+06)
or ImagePro, our solution provides a unique and dedicated approach for HTS image
analysis. It allows end-users to perform high-profile cytomics with a minimum level of
a prior experience on image analysis and machine learning. The system is modular
and all modules are implemented in the form of web services, therefore, updating
the system is virtually instantaneous. Moreover, the framework is very flexible as it
allows connecting other web services. Consequently, a fast response to new progress
in image and data analysis algorithms can be realized. Further integration with online
bio-ontology databases and open gene-banks is considered so as to allow integration
of the data with other resources. Therefore, the platform can eventually evolve into a
sophisticated interdisciplinary platform for cytomics. Having the screen information




This chapter describes our approach in CytomicsDB for building a semantic layer over the data
so as to enable querying metadata and at the same time allowing scientists to integrate new tools
and APIs taking care of the image and data analysis. These analysis results will become part of
the metadata of the whole HTS experiment and will be available for semantic post analysis.
This chapter is based on the following publication:
• E. Larios, Y. Zhang, L. Cao, and F.J. Verbeek. Cytomicsdb: A metadata-
based storage and retrieval approach for high-throughput screening ex-
periments. Pattern Recognition in Bioinformatics (PRIB 2014). Lecture Notes
in Computer Science, vol. 8626, Springer International Publishing, pages
72–84. 2014.
3.1 Introduction
High-Throughput Screening (HTS) is a well-established process in drug discovery for
pharma and biotechnology companies and is now also being set up for basic and ap-
plied research in academia and some research hospitals (MF08). Recent developments
in microscopy systems and robotics enabled large-scale screening of cellular systems. A
popular screen setup is automated time-lapse confocal image acquisition which enables
capturing of e.g. high content subcellular information (derived as features) or dynamic
aspects like cell migration. Cells are exposed to hundreds and even thousands of
different conditions using one or several multiwell (96, 384, 1536) plates. This typically
results in 20-40 GB of data consisting of in the order of 100,000 - 200,000 images in an
overnight experiment.
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In cytometry, HTS-experiments are usually employed in the context of functional
analysis, closing the gap between genomics-proteomics and functional responses on
the cellular level. Examples are genome wide siRNA screens, where all existing genes
are lowered in activity one at a time using siRNA mediated knock down followed
by some cellular-level phenotypic readout, e.g., cell migration speed, focal adhesion
dynamics, subcellular morphological changes, cell death.
A next step in the HTS-experiment pipeline is image quantification using image
analysis software tools. In this manner, biological hypothesis can be statistically tested
using the quantification results from the image analysis stage, and can depict an
objective understanding of the cell response to various treatments or exposures.
In a typical HTS workflow, spreadsheet applications are commonly used for book-
keeping all information related to the design of the multiwell-imaging plates, image
analysis quantification results and even statistical analysis results. This approach has
many drawbacks. Firstly, it is extremely difficult to link the data produced during the
different stages of an HTS experiment, such as linking the images generated in the HTS
experiment and the metadata collected during the design of the plate layout. Secondly,
it is highly prone to man made errors. The lack of standards, formats and a central-
ized place for storing the information makes it difficult to promote a collaborative
environment within or between research groups. Finally, spreadsheet applications are
not suitable for knowledge discovery, as they do not allow to combine sophisticated
visualization and querying of the (meta)data previously stored.
In our previous work (LZY+12), we presented the initial design of a platform
for managing and analyzing HTS images resulting from cytomics screens taking the
automated HTS workflow as a starting point. This platform seamlessly integrates
the whole HTS workflow into a single system. The platform relies on a modern
relational database system to store user data and process user requests, while providing
a convenient web interface to end-users. Using this platform, the overall workload of
HTS experiments, from experiment design to data analysis, can be significantly reduced.
Additionally, the platform provides the potential for data integration to accomplish
genotype-to-phenotype modeling studies. In this work, the initial design, particularly,
the database model, has been rigorously revised and generalised to manage all kinds
of metadata produced by automated HTS systems. We call our system CytomicsDB,
which is designed as a user oriented platform but considers the HTS workflow as a
template for managing, visualizing and querying the metadata.
Current software and architectures for HTS are mostly based on generic Lab In-
formation Management Systems (LIMS) (WSP+07), which face significant challenges
for accessing, analyzing, and sharing the data required to drive day-to-day processes
within the laboratory. Furthermore, the limited connectivity to other legacy systems
and poor visualization of the data is an obstacle to extract new insights from the data
stored, and cause a deep impact in the efficiency of the HTS experiment. Comparing
with the existing LIMS systems, CytomicsDB has a number of important advantages:
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1. Ease of promoting scientific collaborations. Since all data in CytomicsDB are
centralized, granting access to collaborators or sharing information has been
made simple.
2. Flexibility for integration with other legacy systems. It it common to use external
APIs for performing image and data analysis results, such as Weka, PRTools.
In the design of the architecture of CytomicsDB, special care has been taken to
assure the possibility of invoking external API through web services.
3. The web-based architecture allows users easy access to their experiments data
from wherever and at any time. The architecture also allows the whole or parts
of the system to be smoothly moved to a Cloud based environment.
4. The capability to drill-down through experiments metadata due to the metadata-
based approach.
5. A single interface for visualization of all experiments data, including raw images,
metadata and analysis results.
6. Pattern recognition (PR) within an experiment and PR across HTS experiments.
To sum up, the contributions of this work include:
1. Metadata organization in an HTS experiment (Section 3.2).
2. A case study in endocytosis of epidermal growth factor receptor (EGFR), describ-
ing how a Metadata-based RDBMS approach can facilitate the identification of
EGFR dynamics and classification of EGFR phenotype stages (Section 3.3).
Finally, in Section 3.4 we discuss related work and in Section 3.5 we present our
conclusions.
3.2 Metadata organization in an HTS experiment
The metadata of an HTS experiment consists of a variety of types and formats and has
been grouped in five levels as showed in Figure 3.1: Project, Experiment, Plate - Wells,
Video/Images and Measurements. These levels contain each other in a cascade fashion,
for instance: [1] Project contains [1..n] Experiments, [1] Experiment contains [1..n]
Plates, [1] Plate contains [24,48,96,384] Wells, [1] Well contains [1..n] Video/Images and
finally [1] Well contains [1..n] measurements.
3.2.1 Project
This level contains a title which describes the aim of the project, the duration, the author,
etc. When a project is created, its creator becomes its administrator and is possible to
grant access to another scientist in order to promote a collaborative environment.
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3.2.2 Experiment
Figure 3.2 shows the structure of the metadata contained in the Experiment level.
This level is divided in Hardware and Type of Experiment. Firstly, the metadata
associated to the hardware correspond to the microscope and the imaging technique
used. Depending on which microscope is used, the set of imaging techniques differs.
For instance, the imaging techniques available for a Becton Dickinson (BD) Pathway
microscope are EPI, Spinning disk or Bright Field, but in a Nikon TE 2000-e microscope
it is possible to use: FRAP, FRET, EPI, Confocal, Spectral or DIC. Secondly, the metadata
associated to the type of experiment can be separated in four groups: (1) Fixed or Live
experiment including a 2D or 3D option for each case; (2) Assay type, in this case there
are the following options: migration/invasion, proliferation, primary tumor, apoptosis
and sub cellular perturbations; (3) Species, the options available are: human, rat, mouse
and zebrafish; and (4) Cell / Tissue origin, considering in this area: primary, cell line,
iPSC, stem cel, biopsy, etc.
Figure 3.1: Structure of the metadata in an HTS experiment
3.2.3 Plate-Wells
This level is also divided into two groups: metadata about the Hardware and about
the Parameters used. Figure 3.2 shows a diagram of the structure of these two groups.
The Hardware sub level includes information about the plate type, the brand and the
fabrication material. The level of Parameters includes information about (1) Coating, (2)
Cell-line / tissue, (3) treatment, (4) siRNA, (5) Antibodies / reagents and (6) Parameters
of control or comments. The metadata of Wells is a subset of metadata of the plate level.
For instance, in a 8x12 wells plate, different wells can have a subset of the parameters
assigned to the whole plate. This level is also associated with the output of the HTS
process (Raw Video / Images) and with the results of the image and data analysis
phase which is also called measurements.
Part of the metadata at this level is critical information that should be verified
and validated when it is uploaded. For instance, the parental cell line/tissue, or the
treatment and its concentration are just two cases which the entry is verified in a
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Figure 3.2: Structure of the Experiment and Plate metadata
first instance (obligatory data) and then they are validated with the information pre
loaded in the imaging database. In order to keep the consistency of the metadata it is
necessary to validate each entry and when a new value is detected the administrator
of the platform is in charge of accepting this new entry as valid or correct to the right
value if it is necessary. The consistency in the metadata is a key task in the imaging
database because the obligatory data will be further used as a controlled vocabulary
for querying.
Figure 3.3: Structure of the Raw Images metadata
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3.2.4 Raw Images
Raw images are obtained after image acquisition with automated microscopy systems.
These images are the basis for the image analysis which results in quantitative data
used for hypothesis testing. The response of the cells is recorded through time-lapse
microscopy imaging and the resulting image sequences are the basis for the image
analysis. The structure of an image file depends on the type of experiment (Fixed/Live)
and the microscopy technique used in the experiment. Section 2.4.3 describes four
types of structures supported (cf. Figure 3.3) (LZY+12): (1) 2D (XY), (2) 2D+T (XY+T),
(3) 3D (XYZ), and 3D+T(XYZ+T).
Figure 3.4: Structure of the Measurements metadata
3.2.5 Measurements
This level contains the results of the Image and Data Analysis process (cf. Figure 3.4):
Results of Image Analysis
Section 2.4.4 describes the type of output in the image analysis stage. The goal in this
stage is to convert images into measurements by using image segmentation and object
tracking procedures. These measurements are part of the metadata and are also linked
to the raw video image file, on which the image analysis has been applied.
Results of Data Analysis
Section 2.4.5 describes the results of the data analysis stage. The measurements ob-
tained from the analysis step are stored in the database, and can be queried in order to
perform further analysis using pattern recognition tools. A CSV file is generated with
the results accompanied by a HDF file (Gro10) with information of the structure of the
CSV file (features).
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3.3 Case Study in Endocytosis of EGFR: Identification of EGFR
dynamics and classification of EGFR phenotype stages
In this section we describe a case study on how the structure of the metadata and
RDBMS are applied in order to identify the EGFR dynamics and classify the different
EGFR phenotypes.
Endocytosis is regarded as a mechanism of attenuating epidermal growth factor
receptor (EGFR) signaling and of receptor degradation. Increasingly, evidence becomes
available showing that cancer progression is associated with a defect in EGFR endocy-
tosis (dGCW+13). Functional genomics technologies combine high-throughput RNA
interference with automated fluorescence microscopy imaging and multi-parametric
image analysis, thereby enabling detailed insight into complex biological processes,
like EGFR endocytosis. The experiments produce over half a million images. Such a
volume of images is beyond the capacity of manual processing and therefore, image
processing and machine learning are required to provide an automated analysis solu-
tion for HTS experiments (CYW+11). The total size in average can vary between 500
Mb to 20 Gb of raw images per experiment and CytomicsDB is designed to cope with
the growing data size due to the scalable architecture for storing the images in a File
Server and the metadata of the entire experiment in the database (see Figure 2.6).
According to the methodology described in (CYW+11), three stages are identified:
(1) Image Acquisition, (2) Image Analysis and (3) Data Analysis. We describe each
stage as follows:
3.3.1 Image Acquisition
The experiment “Endocytosis of EGFR” and its respective plates is created in the
CytomicsDB platform. The type of metadata required for creating an experiment and
the plates in our platform is described in Section 3.2. The respective values associated
to each type of metadata have been detailed in (CYW+11). After designing the plate in
the platform, the wet-lab experiment is initiated, which includes the following steps:
(1) cell culturing, siRNA transfection and EGF exposure, (2) fluorescent staining of
proteins of interest and (3) image acquisition. Upon completion of the acquisition
process 960 images are uploaded to the platform which size in total is 767 Mbytes.
These images correspond to a 96 wells plate (cf. Figure 3.5) and for each well, images
are captured from ten randomly selected locations. However, an experiment can consist
of more than one plate and the number of samples per well can differ per case.
3.3.2 Image Analysis
The API in charge of the image analysis, request from the database the location of each
image to process. The query executed is:
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Figure 3.5: Web plate layout
SELECT v.vide_id, v.vide_name, v.vide_url, v.vide_position, v.well_row, v.well_column
FROM HTS.Video v
WHERE v.plat_id = 17;
The value of column plat_id is in this case “17” and it was assigned after selecting
the plate for endocytosis in the web interface. Three steps are performed by this API:
(1) noise suppression, (2) image segmentation and (3) phenotype measurement. The
algorithms and process details are described in (CYW+11). Upon completion of
the image analysis process, the API returns two outputs: (1) The location in the
database of a new set of images and (2) currently, a CSV file containing the features
and the phenotype measurement respectively. The set of images generated are: (a)
Original image: PERK (red), EFGR (green) and nucleus (blue) (cf. Figure 3.6(a)), (b)
Component definition: artificial cell border (red) and binary mask of protein expression
(green) (cf. Figure 3.6(b)), (c) Cell border reconstruction: artificial cell border (W-V)
(cf. Figure 3.6(c)), (d) Image segmentation: binary mask of EFGR channel by WMC
(cf. Figure 3.6(d)) (YV12). The phenotype measurements (CSV file) are parsed first
and then stored in the database by a web service. For instance, in case of the first
measurement the following query is executed:
INSERT INTO HTS.Measurement
(Obje_id, Feat_id, Plat_id, Chan_id, Imag_id, Sect_id, Fram_id, Vide_id)
VALUES (0,1,17,1,1,1,1,1,14.0);
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(a) Original image (b) Component definition
(c) Cell border reconstruction (d) Image segmentation
Figure 3.6: Example of set of images generated during the Image Analysis stage
(YV12)
In this example, the column Feat_id=1 corresponds to Area in the entity Feature and
the measurement obtained for this feature is 14.0. The column Plat_id is still 17 because
we refer to the same plate.
The measurements are categorized in two subgroups: (1) basic measurements of
the phenotypes covering shape descriptors and (2) the localization phenotype describ-
ing the assessment of the correlation between two information channels. The basic
phenotype measurement includes a series of shape parameters such as: size, perimeter,
extension, dispersion, elongation, orientation, intensity, circularity, semi-major axis
length, semi-minor axis length, closest object distance and in nucleus, these can be
extended as the experiments so dictates. In addition to the basic phenotype measure-
ment, localization measurements can be derived for a specific experimental hypothesis.
The localization phenotypes are quantifications of comparative measurement between
information channels such as relative structure-to-nucleus distance or structure-to-
border distance. The features in EGFR-screen based localization phenotypes used
are: nucleus distance, border distance and intactness. On the basis of the phenotype
measurements, objects are classified into phenotypic stages. For the assessment of
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significance statistical analysis is performed (CYW+11). Upon completion of the image
analysis, it is possible to visualize the results in a web plate layout and export the
measurements to files.
3.3.3 Data Analysis
The aim of the endocytosis study is to quantify the process of EGF-induced EGFR
endocytosis in human breast cells and to identify proteins that may regulate this process.
The EGFR endocytosis process can roughly be divided into three characteristic episodes:
i.e. (1) at the onset EGFR is present at the plasma-membrane; (2) subsequently, small
vesicles containing EGFR will be formed and transported from the plasma-membrane
into the cytoplasm; and (3) finally, vesicles are gradually merging near the nuclear
region forming larger structures or clusters. The characteristic episodes are the read-out
for HTS. Based on this model it is believed that EGFR endocytosis regulators may be
potential drug targets for EGFR-induced breast cancer. Studying each of the stages, i.e.
plasma-membrane, vesicle and cluster, may provide a deeper understanding of the
EGFR endocytosis process (CYW+11).
When the data analysis process is triggered, a web service request from the database
(entities feature and measurement) the results from the image analysis process. The
output of this web service is the location of a file which contains the results of the test
for each siRNA regulator. This file will be requested for the API PRTools for generating
classifications and graphs with the comparison of the results, such as: (1) Weighted clas-
sification error curve, which represents a combination of a feature selection/extraction
method and a classifier algorithm, (2) Results of the feature extraction and (3) Average
number of plasma-membrane (a) and vesicle (b) per nucleus (CYW+11). Consolidating
in CytomicsDB the experiment’s metadata, raw images and images/data analysis
results, facilitates further comparison with the result of other HTS experiments.
3.4 Related work
In the current area of -omics research, various systems/tools have emerged to try to
solve the problem that the existing practice of keeping metadata does not allow for
effective data searching and mining. They are generally referred to as Laboratory
Information Management System (LIMS).
The work proposed by Colmsee et. al. (CFK+11) is probably the closest to Cy-
tomicsDB. The authors defined central requirements for a primary lab data manage-
ment and aspects of best practices to realise those requirements. As a proof of concept,
the authors implemented a pipeline to manage primary lab data of crop plants. The
pipeline consists of i) data storages including a Hierarchical Storage Management
system, an RDBMS and a BFiler package to store primary lab data and their meta
information; ii) the Virtual Private Database for the realisation of data security and
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the LIMS Light application to iii) upload and iv) retrieve stored primary lab data.
Compared with this work, CytomicsDB has a more sophisticated data model to cope
with different types of data (i.e., images, videos, and data produced in different steps
in an HTS experiment), pays special attention to the extensibility of the architecture to
enable adding new tools.
In (NSD+10), the authors presented three open-source, platform independent soft-
ware tools for genomic data: a next generation sequencing / microarray LIMS and
analysis project center (GNomEx); an application for annotating and programmatically
distributing genomic data using the DAS/2 data exchange protocol (GenoPub); and
a standalone Java Swing application (GWrap) that provides a GUI for the command
line analysis tools. CytomicsDB provides similar functionalities as these tools, but
focuses on dealing with Cytomic data. Moreover, for the design of CytomicsDB, we
have deliberately chosen for a single integrated system to include all features required
for conducting HTS experiments and analysis, instead of individual tools and enabling
high profile pattern recognition.
In (WSP+07), the authors describe a general modeling framework for laboratory
data. The model utilises several abstraction techniques, with focus on the concepts of
inheritance and meta-data. In this model, distinct regular entity and event schemas
can be defined and fully integrated via a standardized interface. The design allows
definition of a processing pipeline as a sequence of events. A layer above the event-
oriented schema integrates events into a workflow by defining processing directives,
which act as automated project managers of items in the system. This LIMS is built
on the Oracle RDBMS, and is maintained by multiple database administrators (DBAs).
While with CytomicsDB, our goal is to meet the needs of HTS experiments with a
more light-weight, flexible system. By adapting modern web and database technolo-
gies, CytomicsDB is easy to maintain and extend (i.e., allowing integrating new tools
naturally).
The work by Chan et al. (CMS06) focuses on interactive visualization methods for
data generated by HTS experiments. The visualization methods might be adapted
by CytomicsDB. However, CytomicsDB is a much more comprehensive information
system for HTS data, because it integrates both experiments and analysis data into a
single system, and allows various types of users and groups to be defined.
Based on the Golm Plant Database System, Köhl et. al. (KBL+08) devised a data
management system based on a classical LIMS combined with web-based user inter-
faces for data entry and retrieval to collect this information in an academic environment.
This system stores plant cultivation units in an MS ACCESS database, which would
quickly run into scalability issues as the data size grows.
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3.5 Conclusions and Future Work
In this chapter, we have presented a metadata based storage and retrieval approach for
organizing data in High-Throughput Screening experiments. Our goal is to facilitate
the exploration process in the HTS workflow, scientist are aware of semantics and
they are pushing forward the need for new approaches in organizing the metadata
according to which queries are mostly applied on the data. In HTS, images by itself
do not have any meaning, but linking images to their respective metadata allows
researchers to learn from their experience and help them in mentalizing semantic
structures of the metadata. Finally, we plan to extend CytomicsDB architecture to
a more sophisticated interdisciplinary platform for cytomics. The structure of the
metadata proposed in this chapter will further evolve to an ontology based framework.
A new layer to the architecture will be added in order to perform semantic queries,




This chapter describes our research in the validation process as performed in CytomicsDB.
This system is a modern RDBMS based platform, designed to provide an architecture capable
of dealing with the strict validation requirements during each stage of the HTS workflow.
Furthermore, CytomicsDB has a flexible architecture which support easy access to external
repositories in order to validate experiments data.
This chapter is based on the following publication:
• E. Larios, Z. Xia, J. Slob and F. J. Verbeek. A semantic-based metadata valida-
tion for an automated High-Throughput Screening workflow: Case study
in CytomicsDB. NETTAB 2015 - Integrative Bioinformatics 2015. (Submit-
ted).
4.1 Introduction
High-troughput screening (HTS) assays provide a way for researchers to simultane-
ously study interactions between large numbers of potential drug candidates with
a target of interest. Significant volumes of data are generated as a consequence of
conducting HTS experiments, making it cumbersome to store, interact, and throughly
mine the data for biological significance (MCV+06).
Due to the large amount of resources invested and the complexity of the processes
performed during an HTS experiment, it is convenient and necessary to build an
automated workflow system which will be in charge of the management, supervision
and validation of the data in every stage of the workflow. In our previous work
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(LZY+12), we presented the initial design of an automated workflow system and in
(LZCV14) we have given more detailed description about how it works in a case study.
Our automated HTS workflow (cf. Figure 2.1) is divided in 5 stages: (1) Design, (2)
Image Acquisition, (3) Analysis, (4) Visualization and (5) Storage. This last stage is
performed in parallel with the first 3 stages. It is extremely relevant to give special care
to the information stored in the platform in order to have reliable output available to
display in the Visualization stage.
CytomicsDB is our metadata-based storage and retrieval approach for HTS exper-
iments and it seamlessly integrates the whole HTS workflow into one single system.
The platform relies on a modern relational database system to store experiments data
and process user requests, and at the same time it provides a convenient web interface
to end-users. Using this platform, the overall workload of HTS experiments, from
experiment design to data analysis, can be significantly reduced (LZCV14).
Management of the HTS information is one of the key challenges for drug discovery
and in order to ensure consistency, integrity and reliability of the data stored in the
platform it is compulsory to perform a strict validation process in every stage of the
HTS workflow. CytomicsDB facilitates this validation process using web services which
will prove each critical entry with an internal or external repository. The metadata that
we store become a key parameter for performing further image/data analysis and drill
down the results of different experiments datasets.
To sum up, the contributions of this chapter comprehend:
1. The automated HTS workflow managed by CytomicsDB, identifying the key
validation issues (Section 4.2).
2. The validation strategies applied in CytomicsDB (Section 4.3).
3. The validation workflow developed by CytomicsDB (Section 4.4).
4. The CytomicsDB architecture, identifying the components in charge of the vali-
dation process (Section 4.4).
5. The analysis of the strategies performed in CytomicsDB for solving inconsistency
conflicts (Section 4.5).
4.2 Critical validation in an Automated HTS workflow
In Figure 2.1 is possible to notice that each stage provides critical input data to the next
stage in the workflow and the urgent need to validate the data involved in these steps
become a key factor in order to obtain accurate and consistent results in the whole
process.
In the following sections, it will be described the stages of the HTS workflow which
are subjected to validation activities. The main validation activities are performed
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in the first two stages of the HTS workflow: (1) Experiment design and (2) Image
acquisition. In this way, the metadata strictly validated can be succesfully used for the
next stages e.g. image and data analysis.
4.2.1 Design
This stage entails the most important validation step, i.e the design of the plate and
layout, it is also in charge of linking the experiment metadata with the previously plates
designed. In the design stage the scientist uploads a spreadsheet file to CytomicsDB
containing the experiment metadata at both plate and well level. The use of spreadsheet
applications is susceptible to errors, thus a strict validation process is performed in
two steps:
Pre design validation
CytomicsDB stores critical metadata in special entities called Master Tables, everytime a
new value is stored in these tables, a validation is done by accessing external biological
databases which are supported and validated by the scientific community.
Design validation
The spreadsheet file containing the experiment metadata is validated with the Master
Tables and in case of any inconsistency, a warning is displayed and registered in the
system. The role administrator will authorize the new entry in case of the metadata
was not identified in the master tables or select one of the possible solutions provided
by the system. The administator is also able to track record of changes in the platform.
4.2.2 Image Acquisition
Upon completion of the plate design stage, the image acquisition process begins. This
stage is divided in two steps: Wet-Lab Experiment and HTS Process. In this stage, it
is necessary to validate the image metadata such as: image type, format type, images
naming convention and the settings used by the microscope. These critical metadata is
used for linking the images to their respective wells.
4.3 Validation strategies
The validation process can be abstracted as a strategy. In this strategy, each object
which objectively exists in the real world (e.g. a Compound, or a siRNA) is defined as
an entity E. For each entity, several attributes are assigned to it, like the name, the
ID number and the publisher. The attributes that are used to describe one entity can
be defined as a set: A={a1,a2,...,an}, in which ai (1≤i≤n) means the ith attribute of
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the entity. In this strategy, multiple data sources are involved as well. They can be
categorized as two types. One set is from the lab in which researchers use CytomicsDB
to manage their experiment data. In CytomicsDB, this set is uploaded by researchers
and stored as master tables in the database. Another group of sources are from external
databases. They are used to validate the metadata uploaded by researchers. All
these data sources can be expressed as a collection S={s1,s2,...,sm} in which si (1≤i≤m)
represents the ith data source among the m data sources. Adopted from (YXQZZH12),
the data source si offers a fact value f for the attribute aj of an entity E. different data
sources may have different fact values for a same attribute of the entity. For the entity
E, if aj ∈ [a1, an], f(si,aj) ≠ f(sl,aj), i ≠ l, then a conflict or inconsistency is found
between data source si and sl. In all fact values from all data sources, those who
correspond to the attribute value in the real world are referred to as true value. So the
validation process is in fact a process for identifying true values among all conflicts
between data sources. The relationships among the entity, its attributes and fact values
from different data sources in CytomicsDB are sketched in Figure 4.1. In CytomicsDB,
the idea is to validate the metadata in S2 by data from data sources S1 who have the
same attributes as S2. Conflicts found among data sources during this process indicate
potential inconsistency. There are several available strategies to perform the conflict
resolution which are described in the following section.
Figure 4.1: Relationship between the entity, its attributes and fact values from data sources
4.3.1 Strategies and algorithms
It is common to have an implicit assumption that the content of all the information
sources should be mutually consistent (Mot99) in the approaches for solving incon-
sistency issues between different data sources. A data inconsistency exists when two
entries (or tuples in the relational data model) coming from different information
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sources are identified as versions of each other i.e. they represent the same real-world
object and some of the values of their corresponding attributes differ (Mot01). The
available conflict resolving strategies are then identified by the ways they elaborate this
basic assumption e.g. Trust your friends strategy assumes that the tuples from trustful
data sources are most likely to be the real-world object, then the data under validation
should be consistent with them. Some standard inconsistency resolutions from (BN09)
are listed hereafter.
No gossiping strategy
The basic idea here is that if multiple objects are retrieved from the excution of queries
from different data sources and it is unsure about which object or which value for an
attribute in the object matchs to the real-world one, then just leave them out and only
report on the sure facts, or directly report all of them. This is the strategy used by the
consistent query answering approaches (FFM05). This strategy leaves the decision
force to users if all query results are reported, which makes it simple to be implemented.
Trust your friends
In the Trust your Friends strategy it is required to trust a third party who will provide
the correct entries. An assumption is considered that the fact values from reliable
external databases can be treated as true values. Especially when those fact values are
identical to the ones given by researchers, the possibility that those fact values are true
values becomes quite high which can be assumed as 100%. This conflict resolution
strategy is referred as Trust Your Friends (BN06). The key point of this strategy is having
reliable data sources.
Cry with the wolves
The Cry with the wolves strategy pursues a different approach, the entries which correctly
describe the real-world object prevail over the incorrect ones, given enough evidence.
It reflects the principle of following the decision of the majority, of choosing the most
common entries among candidates from all data sources and compare to the one under
validation (BN06). The more data sources involved in the validation process, the better
the strategy work.
Meet in the middle
In contrast with the previous strategies, the Meet in the middle strategy follows the
principle of compromise and does not prefer one value over the other but instead tries
to invent a value that is as close as possible to all present values from all data sources
and compare it to the one under validation (BN09).
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Keep up to date
This strategy uses the most recent entries from external data sources to compare to the
one under validation. Some additional time-stamp information about the recentness is
required in order to do the comparison (BN06).
4.4 Implementation
There are usually two types of data inconsistency (BN06): contradictions and duplica-
tions. For the contradictions, they may be caused by typos, version updates, shuffle
of attributes, etc. Perceiving duplications for entities with unique identities is easy.
The validation can be performed on the identifier attributes. Otherwise, additional
identifier attributes are needed to perceive duplications, which add complexity to the
problem. The goal of the validation process implemented in CytomicsDB is to detect
and correct the inconsistent data in the entities of the metadata.
4.4.1 Validation subjects
In CytomicsDB, metadata attributes are mapped as fields in each table which are called
master tables. All the metadata stored in CytomicsDB can be validated for internal
consistency to increase the accuracy and reliability of the metadata for HTS experiments.
In this paper, compounds which have only one attribute without unique identifier and
siRNAs which have several attributes beside unique identities are used as test cases
for the implementation of the validation process.
Compounds
Compounds is one of the key entries in the HTS experiments metadata. In CytomicsDB,
only the name of each compound is adopted. The consistency of this name can be
validated by using the NCBI PubChem Compound database (BWTB08). For instance,
in case of validating the compound ETOPOSIDE. The researchers just offer the name
of the compound. The validation process needs to check if the compound’s real name
is ETOPOSIDE and if it has been registered in the master table by another name. The
following results are shown in Table 4.1 after querying in the NCBI database using the
compound given name.
It is possible to see in Table 4.1 that the name for a compound is not an unique
identifier. A compound entity can be described with several kinds of names like the
source name, the Medical Subject Headings (MeSH) terms, the synonym names, etc. A
compound entity can have multiple names in each category as well (e.g “71316630”
compound has two synonym names).
The CID (PubChem Compound Identification) is a non-zero integer PubChem
accession identifier for a unique chemical structure. So it can be used as additional
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Table 4.1: Query result after checking for ETOPOSIDE in the NCBI database.


















information to detect duplications. As shown in Table 4.1, the molecular weight and
formula are the most distinguishable attributes for the researchers. So these two
attributes are included into the process to assist the researchers to take a final decision.
The 2D structure of each entity is also used in a similar way.
siRNAs
Small interfering RNA (siRNA) (Han02) is a class of 20-25 base pairs in length, dou-
ble–stranded RNA molecules. In common cases, the siRNA is designed as a gene
knockdown tool to interfere with the expression of specific genes with complementary
nucleotide sequences. siRNA inhibits expression from its homologous gene, i.e. the
sequence of siRNA is a sub-sequence of its homologous DNA’s sequence. The symbol,
ID, accession number and GI number of the siRNA follows the homologous gene
as well. Usually one of the double strands of a siRNA sequence is recorded in the
database. The sequence of a siRNA referenced in the rest of this paper refers to a one
strand sequence if it is not specified. For HTS experiments, the siRNA target is of
crucial importance. One typical example of a siRNA provided by the researchers is
listed below in Table 4.2.
Table 4.2: siRNA example provided by the researchers.






D-004105-01 7272 TTK NM_003318 34303964 P.M.
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The consistency of this siRNA can be validated using external databases such as
NCBI Nucleotide (Miz02), HGNC (HUGO Gene Nomenclature Committee), Gene
symbols/IDs database (BLW+08), BLAST+ (Basic Local Alignment Search Tool) se-
quence alignment application (JZR+08) and EMBL database. The result of searching all
attribute values of the siRNA using the external repositories is shown in Table 4.3.










GeneID: 7272 HGNC IDs 7272 TTK NM_003318 262399359 100% aligned
GeneSymbol: TTK HGNC Symbols 7272 TTK NM_003318 262399359 100% aligned
Accession Number:
NM_003318
NCBI Nucleotide 7272 TTK NM_003318.4 262399359 100% aligned
GI Number:
34303964




100969041 TTK XM_008969441.1 675737708 100% aligned
7272 TTK NM_003318.4 262399359 100% aligned
7272 TTK NM_001166691.1 262399360 100% aligned
Table 4.3 shows that querying with each fact value of attributes in the siRNA
from researchers in external data sources may get different results. For example, as
querying with the fact value “NM_003318" of Accession Number attribute in the NCBI
Nucleotide database, the result entry of siRNA has a different GI number (“262399359")
to (“34303964") the one provided by researchers. This is because the siRNA has a new
version, GI Number “34303964" corresponds to Accession Number “NM_003318.3"
which means the third version of the siRNA while GI Number “262399359" corresponds
to Accession Number “NM_003318.4" which is the 4th version of the siRNA, stored
in the NCBI Nucleotide database. Conflicts like this or conflicts like typos, e.g. the
gene symbol given by the researchers might be miss-spelled or be using a synonym
name, will be detected and presented to the user along with the best matches from the
external data sources, thereupon the user can select one of the options presented or
continue using his own version. It is possible to notice that the result of querying with
some fact value from non-unique attribute may get non-unique results, e.g. searching
the short sequence against BLAST+ application. Searching with Gene ID, Gene symbol
and sequence in external data sources may get multiple results. These results will be
treated as potential candidates. In order to detect duplications of siRNAs in the master
tables, only the attribute duplex number is used due to its unique value.
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4.4.2 The validation workflow
Theoretically, data sources can not be 100% accurate in describing all entities in the
real world. Since the researches should be experts in the metadata that they upload,
the researcher’s decisions are involved as a part of the conflict resolving strategy. The
validation result from “Trust Your Friends” strategy is “passed on” (Pass it on (BN06))
to other researchers to let them decide how to handle possible conflicts. For an entity,
the validation result includes the status of its correctness and some possible solutions
when some conflicts are detected in some attributes. For the entity, the “Highest Qual-
ity” (BN09) entries (in all attributes) obtained from external databases are given as
recommended possible solutions to conflicts. The researchers have the final word on
the conflict resolutions. For entities with only one unidentifiable attribute, additional
fact values from external data sources should be used in the validation strategy. For
entities with several attributes, some multi-objective decision algorithms should be
implemented during the selection of the “Highest Quality” options. The validation
workflow follows “Trust Your Friends” and “Pass It On” strategies while using “Lev-
enshtein distance” and “Multi-Objective Decision” algorithms. There are two branches
separately focusing on single-attribute and multi-attributes situations in the validation
workflow. The two branches follow a common principle of the validation workflow.
The principle is first parsing each fact value, i.e. the attribute value of metadata from
researchers, into a standard unique identifier value by querying it as a keyword in an
external data source, then getting the entries from an external database, considered as
reliable, which uses the unique identifier as a primary key. The validation of Compounds
and the validation of siRNAs can be viewed as two scenarios corresponding to the two
branches of the workflow, respectively.
Compound validation
The whole workflow can be divided in four stages: (1) Get candidates(c.f. Figure 4.2),
(2) Screening and marking duplex (c.f. Figure 4.3), (3) Updating duplex marks (c.f. Figure
4.5) and (4) Cleaning up the validation result table (c.f. Figure 4.4). When the user wants
to insert or update a compound into the master table, the process starts to check
whether the compound name exists in the master table. If so, the name will not be
stored. Otherwise, the process will call the components for validation in this order,
i.e. get candidates → screening → update duplex marks. If the user wants to ignore the
validation results and keep the compound in the master table as it is, the user can
select “ignore" which will call the “clean up" component. If the user wants to delete
the compound from the master table, then after calling the “clean up" component, the
deleting action in the master table will follow.
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Figure 4.2: Get candidates
siRNAs validation
This is the case for validating multi-attributes entities. 5 types of siRNA attributes
can be validated with external data sources. They are: the Gene ID, the Gene Symbol,
the Accession Number, the GI number and the sequence. Since the Duplex Number (it is
only used on the master table as a unique identifier which cannot be validated with
external data source) attribute is registered on each siRNA entry in the master table,
only a basic duplex validation of siRNAs is adopted, i.e. assuming that the Duplex
Number of the siRNA provided by the user is reliable, then only checking if the duplex
number exists in the master table is enough. To do the validation, not all the 5 kinds of
attribute values can be directly used as input fields for query in external data sources.
Meanwhile, not all the 5 attributes are included in the query output for each external
data source. The supported types of attributes for query input/output in external data
sources are listed below in Table 4.4.
As shown in Table 4.4, each data source has some specified input fields (e.g. only
BLAST+ application can search with a sequence and only HGNC databases can search
with Gene ID/symbol, etc.). And not all five fields are available in the output siRNA
entities (in fact only NCBI Nucleotide database support all fields in the output). How-
ever, all these data sources do have a common field, “Accession number”, in the output.
The Accession Number or also called “GenBank Accession Number" is a unique identifier
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Figure 4.3: Screening and Marking






HGNC IDs GeneID GeneID, GeneSymbol, Accession Number
HGNC Symbols GeneSymbol GeneID, GeneSymbol, Accession Number
NCBI Nucleotide Accession Number, GINumber




sequence Accession Number, GINumber, sequence
given to a DNA entity record to track versions and associated entities over time of the
entity record in a data repository (BKMC+12). A standard example of an accession
number in Table 4.3 is “NM_003318.4" (MKSP00). It is a combination of an accession
prefix (“NM_003318") and a version number (“4"). If the sequence of the DNA entity
changes, the accession prefix will remain the same but the version number will be
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Figure 4.4: Clean up
incremented. GenBank GI number, however, will change each time the sequence
changes – even if only one base is affected. So the accession number is used as a common
identifier in the validation process.
An example of a user-provided siRNA is given in Table 4.5. Attribute values from
“Oder Number", “Pool Catalog Number" and “Duplex Number" are not possible to be
validated with external data sources as they are only defined and used internally in
the laboratory. So they are not considered in the validation process. In Table 4.5, these
fields are in gray.
In the first step to validate this siRNA, each attribute in the entity is parsed by
a separate parser. The multi-attributes validation problem is then transformed into
a single-attribute validation problem. Similar to the the Compund validation, the
first step of the validation process is to parse each attribute into an unique identifier
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Figure 4.5: Update duplex marks









i.e.,“Accession Number" by using external data sources. The list of Accession numbers
obtained varies from database to database according to the filters . For instance, the
accession number returned from the “HGNC database omits the version suffix number.
For a given “Accession number without a suffix number queried in the NCBI Nucleotide
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database (i.e. “NM_003318"), the returned accession number is always the latest version.
The Accession number provided by the scientist is usually without suffix version. The
result of the first stage is listed in Table 4.6.
Table 4.6: List obtained after first stage of siRNA validation
Input field and value Parsed to External data source
Gene ID: 7272 NM_003318 HGNC Gene ID
Gene Symbol: TTK NM_003318 HGNC Gene Symbol
Accession Number: NM_003318 NM_003318 NCBI Nucleotide





The duplicated results are omitted from the list before sending the list to the next
step. If there is some inconsistence between the siRNA entry provided by the user
and the siRNA entry found in external data source, it is due to the version update.
This means there is a comparatively higher chance to find a perfect match in one of
the versions of the siRNA. So the next step is to find all existed version suffixes for
accession numbers retrieved from the first step. The RNAs associated to those accession
numbers (with version suffixes) are used as candidates for the next step. The latest
version of the accession numbers are fetched from the NCBI Nucleotide database by
NCBI Eutilities EFetch web service (Say08). An iterator then is applied on the version
suffix to get a list of accession numbers from version one to the latest one. For those
accession prefixes in the first step, the list of associated accession numbers is showed
in Table 4.7.
Table 4.7: List obtained after second stage of siRNA validation







Using these accession numbers, queries are executed in the NCBI Nucleotide
database obtaining the results displayed in Table 4.8.
Some candidates have several names in Gene Symbol attribute (e.g. “TTK; ESK;
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NM_003318.1 4507718 7272 TTK; MPS1L1 P.M.
NM_003318.2 23308721 7272 TTK; ESK; MPS1L1; PYT P.M.
NM_003318.3 34303964 7272 TTK; CT96; ESK; FLJ38280; MPS1; MPS1L1; PYT P.M.
NM_003318.4 262399359 7272 TTK; CT96; ESK; MPH1; MPS1; MPS1L1; PYT P.M.
XM_008969441.1 675737708 100969041 TTK P.M.
NM_001166691.1 262399360 7272 TTK; CT96; ESK; MPH1; MPS1; MPS1L1; PYT P.M.
MPS1L1; PYT” for the “NM_003318.2" entry). This is because one siRNA can have sev-
eral synonym names. When candidates are retrieved, all these synonym names will be
collected and linked to the official gene symbol in the Gene Symbol field. Subsequently,
if the siRNA provided by the researchers use a synonym name, the validation process
is able to detect it and give a warning to the user.
The fourth step is to use several comparators in order to calculate the similarity of
each attribute between the candidate and the siRNA provided by the researcher. The
result of this step is a matrix of size n × 5 where n is the number of candidates. Each
row in this matrix corresponds to an entry of candidates and each column corresponds
to each attribute. The similarity score is stored in each cell of the matrix. Given one
candidate sc, the siRNA s from the researcher and the Levenshtein distance similarity
grading function ld (attr1: string, attr2: string) (Lev66). The matrix obtained from the
fourth step is displayed in Table 4.9.


























Candidate 1 0.0056 1 < 1, 0 > 1 1
Candidate 2 0.1051 1 < 1, 0 > 1 1
Candidate 3 1 1 < 1, 0 > 1 1
Candidate 4 0.0792 1 < 1, 0 > 1 1
Candidate 5 0.0792 0.07 < 1, 0 > 0.0056 1
Candidate 6 0.0903 1 < 1, 0 > 0.0056 1
The fifth step of the process is to use the multi-objective decision method (MA04) to
screen best candidates and feed it back to the user for a decision. If a perfectly matched
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candidate is found then the user will get a positive feedback, for instance the candidate
3 in Table 4.9 scores 1 for all comparators except the Gene Symbol comparator. For the
Gene Symbol comparator, other cells in the returned tuple is 1, this is a perfect match
for the siRNA. If no perfectly matched candidates are found, then an error message
along with the top 3 best matched candidates decided by the multi-objective decision
method will be sent to the user. If the perfectly matched candidate is targeted, it is still
needed to check if a new version of the gene name exists in an external database (e.g.
the candidate 4 in Table 4.9) or if the candidate is using a synonym name (the value
of the first cell in the Gene Symbol comparator returned tuple is less than 1 while the
second cell value is 1). If so, a warning message will be sent to the user. The user can
choose to ignore the solutions from the validation process or select one as the correct
one. In both cases the decision is stored in a log where the Administrator can trace the
changes performed in the Master Table.
4.4.3 The architecture
The architecture is designed to accurately follow the HTS experiment workflow de-
scribed in section 2.2, considering four key activities: Acquisition, Visualization, In-
tegration and Exploration. The acquisition consists of two steps: image acquisition
and metadata formulation. The visualization is a key factor in this architecture due to
the large amount of images produced in the HTS process. All these images should be
linked to the plates designed in the acquisition activity. The integration is concerned
with the tasks of image and data analysis which are performed by external applications.
However, the output related to certain metadata is also included in the experiment.
Therefor it is necessary to integrate external APIs to the architecture through web
services. Finally, the exploration is associated to querying the data and the results.
This task is also a key step in order to verify if the experiment requires a new iteration,
possibly making some adjustments to the plate design.
Following the workflow of an HTS experiment described in Section 2.2, CytomicsDB
uses a four-layered architecture (Fig. 2.6). The performance, stability, speed and
scalability are main concerns for the architecture due to the overhead of connecting to
external web services and loading a BLAST+ local sequence database into the RAM
which are relatively heavy tasks during the validation process. Besides that, since the
workflow relies on external applications (e.g. BLAST+ gets different I/O schema in
Windows and Linux), it is needed to concern about the compatibility across different
operation systems.
The validation process consists of four main activities: retrieving candidates, screen-
ing candidates, reporting inconsistences, and updating master tables according to
user‘s decision. The four activities are distributed in several components which in-
teract with each other. The component diagram in Fig. 4.6 shows the interaction
between these components. These components operate within CytomicsDB using the
four-layered architecture.
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Figure 4.6: Components diagram of the validation workflow
The presentation layer
The validation process is functionally enabled for users using a single web based
graphical user interface. The presentation layer supports the GUI for users. Coded in
the JSF 2.0 and PrimeFaces 4.0 front end framework which fully support HTML5 and
JavaScript/AJAX (see fig. 4.6(a)), the presentation layer makes it easier for users to inter-
act with data in master tables (LZY+12). Users can send requests to batch-upload a list
of entries into the master tables, create or update a single entry in a master table, view,
or delete one entry. The validation process will be triggered by the user operations on
the presentation layer. During uploading or creating a new entry in the data repository,
the validation process will be triggered to validate it at the back end. While the user is
viewing the detail of one entry, the validation result and recommended solutions are
showed synchronously. For instance, Figures 4.7(a), 4.7(b), 4.7(c), and 4.7(d) show the
interfaces for the case of siRNA validation. Users with the right privileges can directly
select one candidate the web interface to correct the detected inconsistency or keep the
current one in the master table (see fig. 4.8). The selection will be updated into the data
repository by the validation process. After the user has deleted or updated an entry
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from the master table, the validation process will be called to update the duplicated
information in the validation result table if it is necessary. Besides that, the presentation
layer is the first stage of validation in the platform by considering mandatory fields for
uploading experiment metadata. The presentation layer also manages the messaging,
thus the errors detected during the validation process will be reported to the users by
an alert message on the interface.
(a) Entry passed validation (b) New version found in an external database
(c) Typo detected in the GeneID and Accession
Number
(d) Confirm update
Figure 4.7: Interfaces for validating a new siRNA entry
Figure 4.8: Validation result interface
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The service layer
The service layer is described in Figure 4.6(b), it includes manage beans and several
utilities such as parsers and comparators. They work as the pivot in the validation
process to control the generation of candidates, the screening of candidates and the
responding actions after the researcher makes a choice on the presentation layer. The
manage beans are controllers which request to the utilities to visit resources from external
web services (or applications) and do calculations (c.f. Fig. 4.6(c)). They also control the
calling of internal web services in the service layer to do CRUD (create, read, update
and delete) actions in the master tables. The results obtained are collected and sent
back to the presentation layer (c.f. Fig. 4.6(a)). The purpose of designing the utilities as
independent components from the manage beans is to make the parallel execution of
the utility instances easier.
The service layer also consists of multiple web services that support every step in
the HTS workflow. These web services invoke different APIs which are in charge of
the Experiment design, Image Analysis and Data Analysis (LZY+12). This structure
allows easy scalability adding more functional modules. For instance, parsers in the
utility module use web services to access external data sources. The Simple Object
Access Protocol (SOAP) messages are selected for invoking the web services and
receiving results because of its approved interoperability in web applications and
heterogeneous environments. For these web services, one big portion of work is
keeping the persistence in the database by using modules from the persistence layer
(c.f. Fig. 4.6(d)).
The persistence layer
In section 2.3.3, it is described in detail the role of the persistence layer in CytomicsDB
architecture. In the persistence layer is managed all the SQL code and configuration for
accessing MonetDB database. This layer provides a common data model to the service
layer. This style of architecture facilitates the flexibility and reusability of components
in the web aplication.
The repository layer
The master tables are managed by an open source column-based database system,
MonetDB (www.monetdb.org) (Bon02), which is used as the data repository (c.f.
Fig. 4.6(e)). In the validation process three tables are needed . First, the master table
which contains the object to validate, for instance: “sirna table" or “compound table").
Second, the validation state table, where the validation state (“OK", “Warning" or “error")
for each entity is stored. Finally, the validation details table, where the solutions to correct
the inconsistencies in each entity are stored.
MonetDB has proven to have superior performance in processing analytical queries
on large scale data (BMK09) which is suitable for the complex data manipulation in the
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validation workflow. Thus, in CytomicsDB, MonetDB is used to store the experiment
metadata and validation intermediate results.
4.5 Analysis of conflict solving strategies
In section 4.3 several conflict solving strategies were listed which are available to solve
the data inconsistency issue while doing data integration or validation. This section
explains how the analysis was performed in CytomicsDB for selecting the best strategie
according to the metadata managed by the platform.
4.5.1 Criterias for selecting a strategy
According to (BN09), choosing a specific strategy for a particular data validation
issue can be done by analyzing the following four aspects: (1) System availability, (2)
Information availability, (3) Cost considerations and (4) Quality considerations.
System availability
The “system availability" constraints mainly come from the data properties. One of the
major properties is the input/output value types accepted by the function that imple-
ments the strategy. The four most common types are: numerical, strings, categorical
and taxonomical (? ). The functions available are: (1) Vote, (2) Average/Sum/Median, (3)
First/Last, (4) Most Complete, (5) Most General, (6) Most Similar, (7) Choose Corresponding,
and (8) Most Recent.
The functions that can be used to implement each strategy are listed in Table 4.10.
Table 4.10: Functions used to implement each strategy
Strategies Functions
Trust your friends First/Last, Most similar, Most complete, Choose corresponding
Cry with the wolves Vote
Meet in the middle Average, Median, Most general, Vote
Keep up to date Most recent, first
No gossiping Not applicable
Each function has some preference on value types and data entry types. These
preferences are listed in Table 4.11.
All attributes for siRNA and compound entries are strings, and the functions in
each strategy should support both single and multiple-columns situations, thus some
functions are not applicable for the test cases any more. Table 4.12 shows the list of
available functions and strategies that are supported under the system constraints.
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Most complete All Single-Column
Most general Taxonomical Single-Column
Most similar String Single-Column/Multi-Column
Choose corresponding All Multi-Column
Most recent All Single-Column/Multi-Column
Table 4.12: Strategies and Functions available for siRNAs and Compounds
Strategies Functions System availability
Trust your friends Most similar Implementable
Cry with the wolves Vote Implementable
Meet in the middle Vote Implementable
Keep up to date Most recent Implementable
No gossiping Not applicable Non Implementable
Information availability
There are three major nucleotide databases: GenBank (National Centre for Biotechnol-
ogy Information, or also called “NCBI", EMBL (European Molecular Biology Labora-
tory) and DDBJ (The DNA Databank of Japan). All of them can be queried using SOAP
based web services which their integration to the CytomicsDB platform makes more
easy. Although these three data sources are available to all strategies, the strategies
CRY WITH THE WOLVES, MEET IN THE MIDDLE and KEEP UP TO DATE may need
more data sources in order to be implemented according to the principle of “more data
sources the better result".
Beside these three databases, there are other databases which affiliate to smaller
research groups. They may not have soap based web services which makes their
integration to other systems more complex. Therefore, these data sources are more
complex to be used by the strategies CRY WITH THE WOLVES, MEET IN THE MIDDLE
and KEEP UP TO DATE.
In case of the siRNAs, the sequences can be queried locally in the web server using
the BLAST+ application with its embedded database which is synchronized to the
NCBI repository.
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The smaller databases may have comparatively less maintenance and data are less
reviewed than the other three major data sources. Since there are a lot of them, if
they are included as valid data sources for “CRY WITH WOLVES" or “MEET IN THE
MIDDLE" strategies under the principle of more data sources are better, then the list of
candidates from all data sources will likely includes entries which do not fully correct
describe the real-world facts.
The information availability for the five strategies is listed in Table 4.13.
Table 4.13: Strategies and their information availability
Strategies Functions
Trust your friends Available
Cry with the wolves Less available
Meet in the middle Less available
Keep up to date Less available
No gossiping Available
Cost considerations
CytomicsDB architecture supports multi-threading with minimized I/O (input/output)
operations to all web services. Thus, this makes CytomicsDB comparatively light
weighted. The cost considerations are calculated in terms of the overhead needed in
order to decide the “correct" result for each strategy.
Costs for single-column data attributes The VOTE function or the MOST RECENT
function does not require some particular complex algorithms and have O(n) as time
and space complexity respectively, where n is the number of candidates. The MOST
SIMILAR function can be implemented with other similar algorithms. The available
algorithms for implementing the MOST SIMILAR function are:
1. Longest Common Subsequences (LCS) algorithm: The time complexity is O(m1m2n)
where m1, m2 represent the length of the string and n is the number of candidates.
An optimized implementation is built in The BLAST application for sequence
similarity calculation (Cor88). The space complexity is expected to be O(m1m2n)
as well.
2. Levenshtein Distance (LD) algorithm: Levenshtein (Lev66) proposed the edit dis-
tance algorithm which calculates the minimum numbers of operations (insertions,
deletions and substitutions) for editing one string. The algorithm is sensitive to lo-
cal changes in a single word. The time complexity for this algorithm is O(m1m2n)
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where m1, m2 are the length of strings and n is the number of candidates. The
space complexity is also O(m1m2n).
3. RKR-GST: The major drawback of this algorithm is the time complexity which
is O(m3n) (assuming the length of the two strings are almost the same value m)
in the worst scenario where n is the number of candidates. RKR-GST uses a
hash function to calculate the hash number for each division in the two strings.
This optimized the complexity of GST to O(m2n). The space complexity of this
algorithm is O(nmmax) where mmax is the length of the longest string in the two
strings.
Costs for multi-column data attributes When the MOST SIMILAR function runs in multi-
column mode, it can be attached with different multi-objective decision algorithms as
well. A multi-objective decision algorithm is used to model the decision-maker prefer-
ences. Algorithms are categorized depending on how the decision-maker articulates
these preferences. Considering the overhead and easy-implementing factors, according
to (MA04), in the class of algorithms with no articulation of preferences, the Objective
Sum Method is one of the most computationally efficient, easy-to-use, and common
approaches whose time complexity and space complexity are both O(n). Therefore,
this work uses this approach during the accuracy test and implementation.
The calculation costs for different strategies in single and multi-column mode are
listed in Table 4.14.
Quality considerations
The quality of each strategy is based on the accuracy of the functions used to implement
the strategy. The quality is measured from two perspectives. First, whether the strategy
is able to identify inconsistency in the data under validation. Second, whether the
strategy-selected candidate really reflects the real world object. To do these evaluations,
300 Compounds and 300 siRNAs are used as test cases. 150 items in each category
are randomly modified, forcing them to be invalid by adding, modifying or deleting
one character or digit on each attribute value. To make these manual errors uniformly
distributed, for the 150 modified compound name, every 50 names are modified
by deletions, insertions or substitutions respectively. Similarly for the 150 modified
siRNAs, they are divided into three groups (50 siRNAs in each group) and each
group is modified by using one of the three different operations (deletion, insertion
or substitution). In each group, the operation is performed on a different attribute
(Gene Symbol, Gene Id, Accession Number, GI Number or Sequence) for every 10
entries. The F-measure which is a common measure for test accuracy is adopted as
an indicator to identify the accuracy in finding inconsistency for each strategy. The












The unmodified 150 consistent compound names or siRNAs are considered as the
positive class, and tp, fp and fn denote the number of true positives, false positives,
and false negatives, respectively. For the second criteria, a percentage number named
“True-hit" is considered as the indicator. In this case, 600 (300 Compound names for
the single-column case and 300 siRNA for the multi-column case respectively) proved,
unchanged test cases are considered as the representation of real-world objects. Then
the measure evaluates if each strategy yielded a “correct" candidate based on the 600
real objects (if not, it means that the “correct" candidate is not consistent with the
real-world object). The percentage number shows the percent of matched ones in the
600 real-world objects. In the test, the NCBI database is used as the trustful data source
for TRUST YOUR FRIENDS strategy. The NCBI database and EMBL database are
used as the data sources for CRY WITH THE WOLVES, MEET IN THE MIDDLE and
KEEP UP TO DATE strategies. As the NO GOSSIPING strategy does not work with
the candidates retrieved from external data sources, it is not applicable for measuring
accuracy in this case.
Table 4.14 shows the results of measurement on functions and algorithms in both
single-column and multi-column mode.
4.5.2 Selection of strategies
The analysis for each strategy is listed in Table 4.14. In CytomicsDB, special care has
been taken for considering the highest quality result with as little cost as possible. From
the perspective of the quality, the larger value for F-measure and True-hit indicates the
best quality of the result. According to Table 4.14: The average score for F-measure in
a single-column mode for TRUST YOUR FRIENDS strategy is 0.963 which is larger
than CRY WITH THE WOLVES (0.918) and MEET IN THE MIDDLE strategies, and also
larger than KEEP UP TO DATE strategy (0.902).
The average score for True-hit in a single-column mode for TRUST YOUR FRIENDS
strategy is 0.556 which is larger than CRY WITH THE WOLVES (0.513) and MEET IN
THE MIDDLE strategies, and also larger than KEEP UP TO DATE strategy (0.507).
The average score for F-measure in a multi-column mode for TRUST YOUR FRIENDS
strategy is 0.966 which is larger than CRY WITH THE WOLVES strategy (0.894), MEET
IN THE MIDDLE strategy (0.136), and KEEP UP TO DATE strategy (0.355).
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The average score for True-hit in a multi-column mode for TRUST YOUR FRIENDS
strategy is 0.917 which is larger than CRY WITH THE WOLVES strategy (0.823), MEET
IN THE MIDDLE strategy (0.053), and KEEP UP TO DATE strategy (0.193).
These results indicate that TRUST YOUR FRIENDS strategy with MOST SIMILAR
function gets the highest values among all the strategies. Among all the algorithms
in single-column mode, the LD algorithm gets 0.983 which is slightly higher than
LCS algorithm (0.98) and RKR-GST algorithm (0.925) in F-measure, and it gets 0.573
which is higher than LCS algorithm (0.567) and RKR-GST algorithm (0.527) in True-hit
measurement.
Among all the algorithms in multi-column mode, the LD algorithm scores 0.974
which equals to the score for LCS algorithm and is higher than RKR-GST algorithm
(0.949) in F-measure, and it gets 0.933 in True-hit measurement which equals to the
True-hit for LCS algorithm and better than 0.89 for RKR-GST algorithm.
These statistics show that LD algorithm has better quality results than the other
two algorithms (LCS and RKR-GST) which are available for implementing the MOST
SIMILAR function.
The drawback of TRUST YOUR FRIENDS strategy is the cost concern. For the space
overhead, the memory use when the implementations are running for all strategies
does not have any significant difference in a machine with 8 Gb of RAM. For the time
complexity, TRUST YOUR FRIENDS strategy has the highest time among all strategies
(O(m2n) + O(n) > O(n) > O(1)). However, the complexity cost could be fetched up a
little bit by using the architecture of CytomicsDB. A rough performance test shows,
running with un-optimized RKR-GST algorithm (whose time complexity is O(m3n))
in a multi-threads pathway with minimized I/O (input/output) to all web services,
it will take 200ms (not including the time for fetching candidates from external data
sources) to validate one single-attribute entry or 600ms (not including the time for
fetching candidates from external data sources) to validate a multi-attributes entry
in a Linux system with a stable Internet connection. In the same environment, the
time for fetching all the candidates from all the external data sources takes less than 1
second in a single-column mode and around 4 seconds in a multi-column mode for
CRY WITH THE WOLVES strategy. So the calculation overhead is a comparatively
small portion in the whole overhead for the validation process. Therefore, the time
overhead for TRUST YOUR FRIENDS strategy is still in an acceptable range compared
to its accuracy. As the validation process is performed during the design stage, once
the metadata is uploaded and validated, changes on metadata will be very limited (i.e.
“once created, use forever"). So, the overhead of one round validation can be a less
important issue than its accuracy.
Another major concern is the information availability criteria. As shown in Table
4.14, only TRUST YOUR FRIENDS strategy (except NO GOSSIPING strategy) has full
available data sources because theoretically it requires only one data source, it makes
TRUST YOUR FRIENDS strategy more implementable than other strategies. The results
for system availability are the same for all the strategies except NO GOSSIPING strategy.
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Out of above considerations, the strategy “TRUST YOUR FRIENDS" implemented
with the MOST SIMILAR function (using Levenshtein distance algorithm) is chosen
for the validation process.
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Yes Available O(m2n) + O(n) O(mn) + O(n)
LCS: 0.98 LCS: 0.567 LCS: 0.974 LCS: 0.93











Vote Yes Less available O(n) O(n) 0.918 0.513 0.894 0.823
Meet in
the middle





Yes Less available O(n) O(n) 0.902 0.507 0.355 0.193
No
gossiping — No Available O(1) O(1) — — — —
4.6 Conclusions and Future work
In this chapter, we have presented a semantic-based metadata validation approach
for an automated High-Throughput Screening workflow. Our main goal is to ensure
the integrity, consistency and reliability of the data stored in the platform. This is
a critical requirement for image and data analysis and further data exploration of
the experiment’s results. CytomicsDB architecture has been designed to facilitate the
integration to external repositories. The use of web services makes possible to have
flexibility to access to external databases and validate the key metadata with this public
repositories. Furthermore, aligning the metadata in CytomicsDB to public databases
allow the platform to become an ontology based framework capable to handle semantic
queries and turning the architecture to a web based interactive semantic platform
for cytomics. Finally, we plan to optimize the recomendation results by tuning the
multi-objective decision formula including weights associated to the user‘s previous
decisions. Currently we are giving the same weight to all attributes during the metadata
validation, but including user decision will allow the users to have more accurate
candidates to select.
Chapter5
Cluster Integration for Image
processing and Pattern recognition
In this chapter is described how CytomicsDB supports the integration of cluster computing
for the image analysis stage and how is performed the data processing and pattern recognition
on MonetDB database. It contains also a detailed case study for two commonly used images
analysis algorithms that have been adapted for efficient use on a computing cluster, and explore
the effect on their performance.
This chapter is based on the following publication:
• E. Larios, D. van Es, K. Rietveld and F. J. Verbeek. Cluster integration in
CytomicsDB. (Manuscript in preparation).
5.1 Introduction
In cytomics, the large-scale study of cell systems there is an urgent need to use high
performance and parallel computing technologies due to the large volume of data
managed in different type of experiments. One of the most used techniques in this
area is High-Throughput screening (HTS) where thanks to the use of sophisticated
microscopes a large set of cell images are acquired with taking pictures at a certain
temporal interval. The resulting images can be studied individually, to observe cell
characteristics such as morphology, or analysed as a time lapse series, to observe cell
migration and motility for example.
It was mentioned in Chapter 1 that due to the complexity and variety of types of
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data managed in HTS experiments it was necessary to design an automated workflow
capable of handling the data properly in each stage of the experiment (LZY+12). The
last 2 stages in HTS experiments: (1) image analysis and (2) data analysis receive as input
a large volume of data, effectively it is physically impossible for a human examiner to
go through every image and attempt to extract the required phenotypic measurements.
Therefore, it is mandatory to use a computer-based environment for using image
analysis techniques in order to ensure objective results.
In (YVDvdW09) and (YV12) are described two robust algorithms for image anal-
ysis customized for HTS studies. These algorithms were implemented using the Fiji
software. This software is designed for the biologist and intended for a single user on a
single machine using a sequential approach, interfacing through a GUI. For small tasks
this is a proven setup, but it can prove impractical for high throughput experiments,
with the large data sets often leading to long wait times and delays. A full analysis of
one well plate can take two to three hours. Any possibility to speed up computation
and decrease wait times is therefore highly desirable.
To support computation in the Life Sciences, at Leiden Institute of Advanced
Computer Science (LIACS) has been built the Leiden Life Sciences Cluster (LLSC).
This cluster consists of a fileserver, one user node and 24 worker nodes. This opens
up possibilities to use a scalable and distributed environment for the Image Analysis
stage. Additionally, the repository layer in the architecture of CytomicsDB relies on
MonetDB database which provides a great platform for data analysis and visualization.
The embedded MonetDB.R package serves as a powerful tool for data exploration and
data mining.
In this chapter, we explore how CytomicsDB is integrated to the Cluster system,
how the platform use the adapted image analysis algorithms on the LLSC and the
performance of the resulting parallelized algorithms is also evaluated. Moreover, it is
described the environment for data processing provided by MonetDB.
5.2 The Leiden Life Sciences Cluster
The Leiden Life Sciences Cluster (LLSC) is a computing cluster recently built at Leiden
University. Its intended use is for research related to bioinformatics or other life
sciences. All experiments conducted in this work have been performed on this cluster.
In order to run an application on the LLSC, first the user launches a job. The
job contains information about the computer resources needed for its execution. e.g.
amount of memory, cpus, etc. Moreover, it includes details about the process itself
such as: name, input and output.
In order to guarantee efficient and effective use of the resources, a scheduler is in
charge of the management of the jobs in the cluster. The main goals of the scheduler
are: (1) allocation of computer resources, (2) job execution and (3) report to the user the
output of the execution.
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To analyze large datasets, it has become typical to use clusters of machines to
execute jobs consisting of many tasks. Jobs of many applications coexist on these
clusters and their tasks have diverse resource demands (GAK+14).
The LLSC consists of:
• A single user node, or head node, running the scheduler, i.e. TORQUE (Sta06).
• 24 worker nodes with varying configurations:
– 13 nodes with two dual-core Xeon 5150 CPUs and 16 GB main memory.
– 9 nodes with two quad-core Xeon E5430 CPUs and 16 GB main memory.
– 2 nodes with two dual-core Xeon 5150 CPUs and 8 GB main memory.
– All nodes have 400 GB of local storage in a hardware RAID-0 configuration.
– All nodes are interconnected with 100 MBit/s network interfaces.
• 2 file servers with 7.5 TB as temporary storage in hardware RAID-5 configuration,
32 GB main memory and connected to the network with a speed of 1 GBit/s.
The user node runs the TORQUE Resource Manager. All experiments are run
through TORQUE as jobs. TORQUE is responsible for managing resources, the most
important of which are the allocation of nodes and scheduling of jobs. TORQUE
allows features such as requesting resources, tagging nodes, advanced job logging and
statistics, job arrays and easy integration with third party parallel computing solutions
such as MPI (Message Passing Interface).
5.3 Image Analysis
The experiments in this chapter utilize a standard dataset in cytomics and two Image
Analysis algorithms: (1) Watershed Masked Clustering (YV12) and (2) Kernel Density
Estimation (YVDvdW09), which are image segmentation and object tracking methods,
respectively (CYW+11).
The images obtained from the image acquisition phase are digital images, and as
such they can be processed using digital image processing techniques. The purpose
of the experiments is to measure phenotypic properties. Since phenotype is defined
as the observable characteristics of some object, having some way to determine the
boundaries of that object is critical. The success of both algorithms is highly dependent
upon this. One digital image processing technique designed for this purpose is image
segmentation.
Segmentation is the process of separating an image into its constituent parts or
objects. Usually this means separating the background from the foreground. In our
image samples this is also the case. Each pixel belonging to a cell in the image is
considered part of the foreground, and all other pixels are background. Segmentation
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is considered one of the most difficult image processing tasks (GW06), and also one of
the most important since a lot of subsequent processing techniques are dependent on
the output of the segmentation phase. Separation of foreground and background is
key to further decomposing the foreground into an accurate collection of object masks
that represent individual cells.
It is important to note that the segmentation phase does not have to take the raw
images directly from image acquisition. Segmentation is usually preceded by an Image
enhancement phase. In this phase imperfections in the image such as too much noise or
low contrast can be adjusted to make the image suitable for the segmentation tasks. Our
algorithm makes use of enhancement techniques such as subtracting the background,
gaussian blur, noise suppression and contrast enhancement. There are numerous popu-
lar segmentation techniques, and each comes with their own strengths and weaknesses.
The choice of which technique to use largely depends on the composition of the target
image.
Segmentation methods generally operate on one of two basic properties of intensity
values: discontinuity and similarity. The former uses abrupt changes in an image to
partition the image. The latter attempts to find regions of the image that are similar
in pixel value to each other. Abrupt changes are usually edges of objects. For similar
regions, the notion similar must first be defined. Put simply, for our input images
obtained by fluorescence microscopy, similar pixels have close intensity values to
neighbouring pixels above a certain threshold. The end result is a binary image. Each
pixel was assigned intensity value 1 if it belongs to a cell, and 0 otherwise. The resulting
image is referred to as the mask.
The segmentation step is followed by object tracking. Object tracking algorithms
find links between objects over a time lapse series. This information can be used to
study the movement of these objects over a period of time. In our case, a link must
be found between two objects that appear in consecutive images. Both algorithms are
described in detail in (Yan13).
5.4 Data Analysis and Pattern recognition
In (Ber03), data mining is defined as the process of identifying patterns and relation-
ships in data that often are not obvious in large, complex data sets. As such, data
mining involves pattern recognition and, by extension, pattern discovery.
Bergeron (Ber03) also identifies five major steps in the pattern recognition and
discovery process: (1) Feature selection, (2) Measurement, (3) Processing, (4) Feature
extraction, and (5) Classification and discovery.
Feature Selection. From the universe of available features, the selection of a set of
features or attributes is considered the first step in pattern recognition.
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Measurement. The measurement phase involves converting the original pattern into
a representation that can be easily manipulated programmatically.
Processing. After the measurement process, the data are processed to remove noise
and prepare for feature extraction. Processing typically involves executing a variety of
error checking and correction routines, as well as specialized processes that depend on
the nature of the data.
Feature Extraction. Feature extraction involves searching for global and local features
in the data that are defined as relevant to pattern matching during feature selection.
Clustering techniques, in which similar data are grouped together, often form the basis
of feature extraction.
Classification and Discovery. In the classification phase, data are classified based on
measurements of similarity with other patterns. These measurements of similarity are
commonly based on either a statistical or a structural approach.
5.5 Implementation
Currently there are many open source software tools which assist researchers to per-
form complex image analysis processes in HTS experiments. For that reason it is
relevant for systems that manage experiments data to facilitate the integratation of
those tools to their architecture. CytomicsDB has been designed to assist the whole
HTS workflow (YLL+11), thus the tools used during the analysis stage are easily inte-
grated to our platform through web services. In this section, the architecture will be
described as well as how the interaction between the components in the architecture
are synchronized during the analysis stage.
5.5.1 The architecture
In Chapter 2 CytomicsDB‘s architecture was introduced, it has a four-layered style
architecture: (1) Presentation layer, (2) Service layer, (3) Persistence layer and (4) Repository.
This design allows scalability and flexibility thanks to the easy integration of external
systems to the platform. In this particular case the integration of the cluster LLSC, built
at Leiden University for assisting researchers in the execution of complex tasks during
the image and data analysis where the large volume of data involved demands high
computational resources. In this section the architecture is described from the image
analysis point of view.
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Figure 5.1: CytomicsDB Architecture - Cluster Integration
Figure 5.2: Web Interface for Analysis
The presentation layer
According to the HTS workflow, upon complexion of the image acquisition step and
after uploading the images obtained to CytomicsDB, the analysis process can be
triggered just by selecting a plate in the web interface and then selecting the option for
analysis (Fig. 5.2). This layer also manages the web pages for visualizing the results,
basically phenotype descriptors, binary masks and trajectories.
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The service layer
This layer includes the web services in charge of the management of the analysis
process. This style provides security and it is also a key factor in the integration with
external systems. In this case the integration with the cluster LLSC is straightforward
and independent of the programming language or the operating system running in
each component of the architecture.
The persistence layer
The Java Persistence API (JPA) framework has been implemented in this layer to
keep a bidirectional correspondence between the database and objects. Those Java
objects used in this framework are known as Java Entities (KS06). The entities used in
CytomicsDB map a physical table from the database and are the most secure way to
manipulate and query the data stored in MonetDB.
The repository layer
The image analysis results consists basically of: (1) phenotype data, which is parsed to
the relational database management system and linked to the original image dataset.
(2) Binary masks and Trajectories, these results are also images that are stored in the
File Server, and their location stored in MonetDB (Bon02) (LZCV14).
The Cluster
In Section 5.2 it was introduced the hardware used in the LLSC, the following describes
how it works for the image analysis stage, in particular case for the segmentation and
object tracking.
The input stacks are obtained from the Database. There are three main compo-
nents involved. Two scripts written in Python named PA.py and PA-Seg.py, to setup
the tracking and segmentation experiments respectively. Two TORQUE/PBS job-
scripts using Bash called parallel-tracking.jobscript and parallel-segmentation.jobscript.
Finally, a jar file named PA.jar containing the modified ImageJ source and Java im-
plementations for segmentation and tracking. The ImageJ source is modified so that
GUI components of certain plugins are no longer instantiated. The call hierarchy is
PA.py→ jobscript→ PA.jar. PA stands for Phenotype Analysis. PA.py takes a text file
as its argument. This text file itself contains arguments for the rest of the process. PA.py
creates a global output directory for the job. Each node has read/write privileges for
this directory. It copies a file containing the locations of all input stacks to this directory.
It also copies the jobscript, depending on whether it is a tracking or segmentation job.
The script also passes along any relevant arguments to the jobscript. The last statement
in both Python scripts executes qsub, which is a TORQUE command and instructs
TORQUE to schedule the jobscript. The jobscript submitted to the cluster contains
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a header. In this header the output directory can be specified for all job output and
logfiles. In our case this is the global output directory. These logfiles can later be used
to gather job statistics. Job resources can also be requested. It is possible to request
only nodes of a certain type or with a certain amount of memory. The main feature we
are interested in is the amount of nodes, and the processors per node. Using these two
attributes we can control the total number of resources available per job and measure
how total job execution time reacts to different combinations of nodes and processors
per node. The jobscript controls a selected number of nodes and is responsible for
calling PA.jar on each node with the correct parameters. For segmentation, each node
is given an equal number of stacks to process. If there is a remainder it is again split
over the nodes. Once the node “knows" which stacks it must segment it can run
concurrently with no synchronization until it is finished. For tracking, the jobscript
first calculates the input arguments which it writes to a file on each node. Again,
each node can process its stacks concurrently. When all nodes are finished the joining
operation is started. PA.jar takes different arguments for segmentation and tracking.
For segmentation it takes the input stack, the number of cores to use and the location
of the output directory. Tracking takes the input stack, the masked input stack, the
output directory, the number of cores, and the id‘s of the slices it must process.
MonetDB.R Package
R programming language has become for both academia and industry one of the most
important tools for data analytics, statistics, visualization and data science. Scientist use
R to solve their problems for data processing specially with respect to large volumes
of scientific data. R is also becoming important because it is not only very flexible in
reading, manipulating, and writing data but all its outcomes are directly available as
objects for further programming (Kri09).
One of the challenges of data management in Cytomics mentioned in Chapter 1
is the movement of data, and the need for processing the data “in place" and transmit
only the resulting information. Following this paradigm, MonetDB.R package was
developed for providing a transparent connection to MonetDB from the R software
suite. MonetDB.R was designed to reduce the overhead of shuffling data between
different systems, resulting in the improvment of data processing time. This is achieved
because the package decides which portions of the data analysis should be performed
by either R or the MonetDB database. Thus, the combination of both applications in
CytomicsDB platform speed up the process of data discovery (Mon).
5.5.2 The image and data analysis data flow
The diagram shown in Figure 5.3 illustrates the flows of the control in the HTS image
and data analysis stage. In case of the image analysis, Figure 5.3 shows the steps for
the execution as typical cases of the segmentation and object tracking algorithms. On
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Figure 5.3: Image and Data analysis data flow
the other hand, in case of the data analysis, it is shown the steps for the execution of the
R scripts in order to obtain graphical representations of the large datasets and identify
patterns. The main three features of this stage are (1) the image analysis request, (2) the
data analysis request and (3) the visualization of the results. How this main features are
executed is shown by three sequences of annotated arrows starting from the end-user
GUI. Arrows handling the same operation are grouped together by a major number,
while the alphabetical characters correspond to the order of a particular step that is
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called in its containing sequence.
In Figure 5.3, we describe each of the sequences. Sequence 1 handles the image
analysis request, this request is made from the web interface in CytomicsDB. First,
the request is sent to MonetDB, the location of the image datasets under analysis is
sent to the web service in charge of the management of the analysis process. Second,
the image dataset is extracted from the File Server and then sent to the LLSC for
the execution of the segmentation and then object tracking tasks. Finally, upon the
complexion of the analysis process the phenotye data is stored in MonetDB and the
new image datasets resulted are stored on the File Server, then their location is stored
in MonetDB for further querying. Sequence 2 handles a data analysis request, which is
first sent to MonetDB. Subsequently, the data analysis process is triggered. R scripts
are executed using the package MonetDB.R, this package will manage which part of
the data analysis will be performed in R or in MonetDB database. Sequence 3 handles
the visualization of the results, since the results and experiment‘s metadata is stored
in one single place, the visualization of the results can be handled by just requesting
the data of the analysis results from MonetDB. In the web interface, the results are
displayed with the corresponding plate layout.
5.5.3 Image Analysis setup and Results
Segmentation
This experiment measures job time for an input set of 512 stacks, processed over 1,2,4
or 8 nodes. The images are MTLn3 cancer cells, cultured in 4 different well plates. The
512 stacks are made up of:
• 144 images from well plate 2, not treated.
• 144 images from well plate 2, treated with EGF.
• 144 images from well plate 3, not treated.
• 88 images from well plate 3, treated with EGF.
This experiment utilizes all available nodes and was run 3 times. The results reflect
the average of these runs. There are also an equal amount of jobs as nodes. Figure 5.4
shows how segmentation scales for up to 24 nodes, confirming a linear speedup.
Object tracking
The experiment input is 144 non treated image stacks from well plate 2, and their
corresponding masked versions obtained through prior segmentation. Each stack
has 31 slices. This experiment processes partitions of a stack concurrently but does
not process multiple stacks concurrently. Each image file is read directly from the
File Server and tracked. Once all stacks have been tracked and have written their
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Figure 5.4: Segmentation results using up to 24 nodes
local results the joining starts. Each node sends its results to a master node where the
joining algorithm is run for all stacks. When all algorithms are finished all results are
copied back to the File Server. The tracking, joining and copy operations are all timed
separately. The combinations listed in Table 5.1 were tested.
Table 5.1: Algorithms tested
Algorithm Cores Nodes
Sequential tracking 1 1
Partitioned tracking 1 2-10
Partitioned tracking 2 1-6
Partitioned tracking 4 1-3
Each experiment is run 3 times and the averaged results are given in figure 5.5.
The line represents a linear (ideal) speedup. The chart shows that there is in fact a
significant improvement even when more than 2 processors are used. In some cases a
superlinear speedup is achieved. The use of 1 core per node consistently gives the best
performance. A possible explanation for this is that 1 cpu is used for the algorithm, and
in our implementation the entire node (4 processors) has been reserved by TORQUE.
No other user intensive user processes were running on the remaining 3 cores. As a
result, when 1 core per node is used the entire cpu cache and RAM memory can be
used for tracking without interference. When 2 or 4 cores per node are used these
resources must be shared, possibly causing increased cache miss rates. Using 4 cores
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per node is the slowest option (though it still achieves close to linear speedup). Even
though it is outperformed, using 4 cores per node is still desirable. If one core per node
is used and another user requests the remaining cores for another process performance
may drop beyond that of using 4 cores per node. Even if no such request is made the
remaining cores are essentially wasted. It is worth noting that using 7, 8 or 9 processors
seems to be worse than using 6. This can be explained by the inefficiency of the slice




slices, except the last which also processes the remainder. For 6 nodes, each node
processes (31/6) + 1 = 6 slices. For 7 nodes, each node processes (31/7) + 1 = 5 slices,
except the last which processes 8 slices. Similarly, 8 nodes each process 4 slices, except
the last which processes 11. Each node must complete before the next stack can be
processed. Therefore, when using 7,8 and 9 nodes since there is a node that processes
more slices than when using 6 nodes, 6 nodes is faster. This method of slice allocation
is the most basic easiest to implement method and should be improved in a future
version.
Figure 5.5: Partitioned concurrent tracking and join times
5.5.4 Data Analysis setup
In Section 3.3, it was described a case study which explains how the data model
designed in CytomicsDB supports the image analysis stage. Tables Feature and Measure-
ment are used to store the phenotype data resulted from the image analysis stage, and
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become the base for starting the data analysis process. In Figure 2.11, it was shown the
the database schema for storing the measurements metadata. This section is based on
the case study introduced in Section 3.3. The aim of the case study is to investigate the
process of endocytosis and epidermial growth factor receptor (EGFR) signaling. EGFR
signaling triggers breast cancer cells to escape from the primary tumor and spread to
the lung, resulting in poor disease diagnosis. Moreover, it may result in resistance to
anti-cancer therapy (CYW+11).
Based on the data stored in the tables Feature and Measurement, the data analysis
is triggered. First, it is requested from the database the feature names and the feature
values used in this experiment.
The query executed for retrieving the feature names is:
SELECT f.feat_name
FROM HTS.Feature_plate p, HTS.Feature f
WHERE p.feat_id = f.feat_id and p.plat_id = 17;
The Features are associated to a plate, and in this experiment is being used the plate
identified by plate_id with value “17”. The result set obtained is:
testNr, frame#, obj#, area, perimeter, massCenterX, massCenterY, extension, dispersion,
elongation, orientation, compactFactor, averageIntensity, Nucleolus Dist, Nuke X, Nuke Y,
Number of FAK, Number of Nucleolus, In Nucleolus, Closest FA Dist, long axis,short axis,
Border Distance, Int Std, Int Smoothness, Int Skewness, Int Uniformity, Int Entropy
Thanks to the use of the MonetDB.R package, there is no need to retrieve the feature
values a.k.a. measurements from MonetDB to the web service layer in order to perform
the data analysis. For this particular experiment, the table measurement contains 279
036 rows and 28 features.
A view of the features value stored in the table Measurement can be retrieved
executing the following query:
SELECT f.feat_name, m.meas_value
FROM HTS.Feature_plate p, HTS.Feature f, HTS.Measurement m
WHERE p.feat_id = f.feat_id and p.feat_id = m.feat_id and
p.plat_id = m.plat_id and p.plat_id = 17;
The data analysis process begins with the execution of the R script. This script is in
charge of the following steps: (1) Classification and (2) Comparison of the treatments per
well. In the Classification, for this particular case study (Section 3.3), the measurements
were classified in three subsets: Cluster, junction and vesicle. In order to have this
classification completed, first a ground truth data preparation is elaborated, this will
be used for training the classifier algorithm, then it is necessary to perform feature
selection and feature extraction and finally the feature values will be classified in
one of these subsets. Upon completion of the classification task it is possible to do
the comparison of the treatments per well and identify: (1) Number of vesicles per
nucleus (c.f. Figure 5.6(a)), (2) Number of clusters per nucleus (c.f. Figure 5.6(b)), and (3)
Plasma-membranes (pixel) per nucleus (c.f. Figure 5.6(c)) (CYW+11).
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(a) Number of vesicles per nucleus (b) Number of clusters per nucleus
(c) Plasma-membranes (pixel) per nucleus
Figure 5.6: Comparison of results with three phenotypic groups
5.6 Conclusions and Future work
The use of cluster computing in Bioinformatics research, especially in cytomics, has
been proved to be highly necessary due to the large datasets generated in HTS work-
flows. Due to the advantage of using parallelism in cluster architectures, traditional
algorithms used for instance in image analysis need to be adapted to such environ-
ments. In this chapter, we have presented the cluster integration to CytomicsDB
architecture and explored the effect of parallel computing on the performance of these
algorithms in HTS experiments. We have shown that both segmentation and tracking
algorithms can be parallelized efficiently with segmentation scaling linearly up to at
least 96 processors using a combination of stack and slice level concurrency. Addition-
ally, it has been described for the case study presented in Section 3.3 how the steps for
data analysis are accomplished. Finally, it is still possible to reduce the volume of data
generated in the image analysis stage e.g. auxiliary images such as binary masks and
trajectories. Instead of storing the image files as tiff files, a matrix can be used to store
the location of the objects of interest.
Chapter6
Conclusions and Future work
This thesis addresses our research in the design and development of CytomicsDB, a compre-
hensive data management system for cytomics. This chapter presents the conclusions of the
research. First, it addresses the research questions and the problem statements identified in this
work. Second, the contibutions of this thesis are highlighted and finally the conclusions are
presented, including an outline of future work.
6.1 Research questions and Problem statement
In this section, the evidence collected throughout this dissertation is summarized and
used to address the research questions developed in this thesis. The Problem statement
(PS) and the four Research questions (RQ) developed in this work are listed as follows:
• PS: How to optimally/flexible organize the data managed for cytomics so as to be able to
deal with the data deluge?
• RQ1: Which components and processes are required to build in a data management
platform for cytomics?
• RQ2: How can be addressed the needs of metadata organization handled in Cytomics?
• RQ3: How can we prove the consistency of the metadata managed in Cytomics?
• RQ4: How can we speed up the data processing in Cytomics?
6.1.1 Designing a software architecture for cytomics
• RQ1: Which components and processes are required to build in a data manage-
ment platform for cytomics?
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In Chapter 2 it was highlighted that given the large amount of different conditions
and the readout of the conditions through images, it is clear that the HTS approach
requires a proper data management system to reduce the time needed for experiments
and the chance of man-made errors. Additionally, it was emphasized that due to the
fact that there is different types of data, the experimental conditions need to be linked
to the images produced by the HTS experiments with their metadata and the results
of further analysis. Moreover, HTS experiments never stand by themselves, as more
experiments are lined up, the amount of data and computations needed to analyze
these increases rapidly. To that end it was necessary first to design an automated
workflow for HTS experiments. Subsequently, it was proposed a software architecture
which supports the demands for data management in typical HTS workflows. Finally,
it was presented the database design capable to store experiments metadata and image
and data analysis results.
6.1.2 Adressing the metadata organization
• RQ2: How can be addressed the needs of metadata organization handled in
Cytomics?
In Cytomics, the study of cellular systems at the single cell level, High-Throughput
Screening (HTS) techniques have been developed to implement the testing of hundreds
to thousands of conditions applied to several or up to millions of cells in a single
experiment. Recent technological developments of imaging systems and robotics have
lead to an exponential increase in data volumes generated in HTS experiments. This is
pushing forward the need for a semantically oriented bioinformatics approach capable
of storing large volume of linked metadata, handling a diversity of data formats, and
querying data in order to extract meaning from the experiments performed.
For addressing a solution, in Chapter 3 it was necessary to analyze and categorize
the metadata managed in HTS experiments. The metadata was organized in five
levels according to their role in the automated HTS workflow presented in Chapter 2.
These levels are: (1) Project, (2) Experiment, (3) Plate-wells, (4) Raw images, and (5)
Measurements. Finally, a case study is introduced which describes how the metadata is
managed in CytomicsDB platform. The proper organization of the metadata facilitates
scientist to work with a common data model thus improves the interoperability and
the understandability of the metadata managed by the system.
6.1.3 Metadata validation
• RQ3: How can we prove the consistency of the metadata managed in Cytomics?
High-Throughput Screening (HTS) techniques are typically used to identify po-
tential drug candidates. These type of experiments require invest in large amount
of resources. The appropiate data management of HTS experiments has become a
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key challenge in order to succeed in the target validation. Current developments in
imaging systems has to cope with computational requirements due to the significant
increment of volumes of data. However, no special care has been taken to ensure the
consistency, integrity and reliability of the data managed in HTS experiments. The
appropiate validation of the data used in an HTS experiment has turned to be a key
success factor in the target validation, thus a mandatory process to be included in the
HTS workflow.
For tackling with these issues, in Chapter 4 firstly, it was analyzed which are the
validation needs in the automated HTS workflow, then it was described the strategies
available for metadata validation and how is the validation workflow developed by
CytomicsDB, the workflow is explained using two case studies based on the Compounds
validation and siRNA validation. Furthermore, it was described the implementation
of the validation strategies in the system architecture. Finally, it was analyzed and
evaluated the validation strategies in order to select the most appropiate ones according
to the type of metadata managed by the platform. The strategy “Trust your friends”
implemented with the “Most similar” function was chosen for the metadata validation
stage.
6.1.4 Speeding up data processing
• RQ4: How can we speed up the data processing in Cytomics?
According to the automated workflow for HTS experiments presented in Chapter 2,
the last two stages corresponds to the image and data analysis. These stages require
high performance computing resources. Moreover due to the large volume of data
involved in the analysis it is mandatory to take into account the location of the data for
processing and how to adapt the algorithms so as can be used in a cluster environment.
It was demostrated in Chapter 5 that based on the two case studies for segmentation
and object tracking algorithms, the performance of the parallelized version of both
algorithms has been improved using a cluster environment. The processing duration
has been reduced from aprox. 1 day to the range between 2 and 4 hours. Finally, it
has been highlighted that in the data analysis stage is relevant to consider where to
process the data. Thus, it has been also described how the MonetDB.R package has
been used in CytomicsDB in order to avoid the overhead of shuffling data between
different systems.
6.1.5 Adressing the Problem Statement
• PS: How to optimally/flexible organize the data managed for cytomics so as to
be able to deal with the data deluge?
With reference to the answers of the four questions I may conclude that it is needed
to design and develop a comprehensive data management platform for Cytomics. A
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platform capable to adapt to the continuos changes in Cytomics environment. Our
platform called CytomicsDB relies on an architecture which is based on components
which facilitate the integration with other systems in the cytomics domain, the exper-
iments metadata has been properly organized so scientist can have a common data
model which promote data collaboration and sharing, and special care has been taken
for ensuring the consistency of the metadata managed by the platform. Finally, data
processing in cytomics is becoming a challenge due to the large volume of information
generated, thus CytomicsDB architecture has been designed to easily integrate the
advantages of clustering computing for the image analysis and to speed up the data
analysis avoiding the movement of huge amounts of data for processing.
6.2 Contributions
To address my problem statement it was necessary to collect data from the Toxicology
Group at Leiden University. The data was obtained by analyzing the protocols, work-
flows, tools, software and harware environment where High-Throughput Screening
experiments are developed. Based on the research findings across this work, it is
possible to highlight the following main contributions of this study:
1. The design of an automated workflow system for HTS experiments.
2. The organization of experiments metadata for providing a common data model
for data discovery, understandability, interoperability and data sharing.
3. Ensure metadata consistency by including a strict validation procedure in the
workflow system of HTS experiments.
4. An integrated platform to automate the data management, capable to speed
up the image and data analysis stage in the HTS experiments workflow by
integrating a computational cluster to CytomicsDB architecture and including
MonetDB.R package for managing the execution of the data analysis requests.
6.3 Future work
During the development of this thesis it was possible to identify other directions for
further research. These other directions are summarized as follows:
1. Reduction of the volume of data generated in HTS experiments. One of the
main challenges for HTS workflow systems is the management of huge amounts
of data, each stage of the HTS workflow generate continuously more data. How-
ever, during the image analysis this amount of data is increased even more due to
the generation of auxiliary image files e.g. binary masks and trajectories. These
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image files are relevant for further analysis of the behavior of the cells exposed to
different types of treatments during the experiment. Avoiding the use of binary
data as an output of the image analysis reduces significantly the resources needed
for its storage and further consultation.
2. Data persistence Other criteria to take into account is related to the data per-
sistence. Relational Databases have been the dominant technology for data
persistence for many years. Most of the databases in life sciences are based on
a relational approach, even with the proliferation of other technologies such as
NoSQL databases (Pok11). There is the possibility that relational databases may
become an issue with the constantly demanding requirements due to the growing
data size and computational resources needed for its processing.
3. Efficient storage of data In the universe of big data there is a tendency to use spe-
cialized distributed file systems e.g. Hadoop (Whi09) instead of typical Relational
Database Management Systems (RDBMS). Unlike RDBMS it is not necessary to
pre design an schema or prepare a sophisticated structure for the data before
using it. The balance between scalability, standards for querying, availability,
interoperability should be analyzed for structured and unstructured data. This
will open the possibility to design hybrid solutions or to evaluate the impact
and costs of turning data from unmanaged to managed, from disconnected to
connected, from invisible to findable and from single use to reusable.
In Cytomics environment, scientist has to continuosly deal with a large volume
of structured and unstructured data, this condition in particular, makes a challenge
the interoperability for any platform developed for cytomics. CytomicsDB approach is
an effort for developing a framework which takes care of the standardization of the
unstructured data, providing a common data model layer for HTS experiments. This
model as well is suitable for the integration with other systems in Cytomics, in special
other repositories, which allow the validation of key metadata used in the experiments,
thus ensure reliability of the data stored. Other possible solutions for cytomics data
management, should take special care in the use of data model standards for enhancing
the collaboration and data sharing in the scientific community.

Bibliography
[Alv] 96 well plate format, http://reinnervate.com/why-alvetex/
alvetex-product-catalogue/, Accessed: 2015-09-25. (cited on
page 11).
[AMF00] George Avery, Charles McGee, and Stan Falk, Product review: Implement-
ing lims: A “how-to” guide., Analytical Chemistry 72 (2000), no. 1, 57
A–62 A. (cited on page 20).
[Ber03] Bryan Bergeron, Bioinformatics computing, Prentice Hall/Professional
Technical Reference, Upper Saddle River, NJ, 2003. (cited on page 82).
[BKMC+12] D.A. Benson, I. Karsch-Mizrachi, K. Clark, D. J. Lipman, J. Ostell, and
E. W. Sayers, Genbank, Nucleic Acids Research 40 (2012), no. Database
issue, D48–D53. (cited on page 63).
[BLW+08] E. Bruford, M. Lush, M. Wright, T. Sneddon, S. Povey, and E. Birney,
The hgnc database in 2008: a resource for the human genome., Nucleic acids
research 36 (2008), no. Database issue. (cited on page 60).
[BMK09] Peter A. Boncz, Stefan Manegold, and Martin L. Kersten, Database archi-
tecture evolution: Mammals flourished long before dinosaurs became extinct,
PVLDB 2 (2009), no. 2, 1648–1653. (cited on pages 34 and 71).
[BN06] J. Bleiholder and F. Naumann, Conflict handling strategies in an integrated
information system. (cited on pages 57, 58 and 61).
[BN09] , Data fusion, ACM Comput. Surv. 41 (2009), no. 1, 1:1–1:41. (cited
on pages 57, 61 and 72).
[Bon02] Peter A. Boncz, Monet: A next-generation dbms kernel for query-intensive
applications, Ph.d. thesis, Universiteit van Amsterdam, Amsterdam, The
Netherlands, May 2002. (cited on pages 33, 34, 71 and 85).
100 Bibliography
[BSV11] L. M. F. Bertens, J. Slob, and F.J. Verbeek, A generic organ based ontology
system, applied to vertebrate heart anatomy, development and physiology., J.
Integrative Bioinformatics 8 (2011), no. 2. (cited on page 52).
[BV08] M. Belmamoune and F. J. Verbeek, Data integration for spatio-temporal pat-
terns of gene expression of zebrafish development: the gems database, Journal
of Integrative BioInformatics 5(2):92 (2008). (cited on page 39).
[BWTB08] E. Bolton, Y. Wang, P. Thiessen, and S. Bryant, Chapter 12 - pubchem: Inte-
grated platform of small molecules and biological activities, Annual Reports
in Computational Chemistry, vol. 4, Elsevier, 2008, pp. 217 – 241. (cited
on page 58).
[CDV08] David Chen, Guy Doumeingts, and François Vernadat, Architectures for
enterprise integration and interoperability: Past, present and future, Comput.
Ind. 59 (2008), no. 7, 647–659. (cited on page 17).
[CFK+11] C. Colmsee, Steffen Flemming, M. Klapperstuck, M. Lange, and
U. Scholz, A case study for efficient management of high throughput primary
lab data, BMC Research Notes 4 (2011), no. 1, 413. (cited on page 50).
[CJL+06] A. Carpenter, T. Jones, M. Lamprecht, C. Clarke, I. Kang, O. Friman,
D. Gertin, J. Chang, R. Lindquist, J. Moffat, P. Golland, and D. Saba-
tini, Cellprofiler: image analysis software for identifying and quantifying cell
phenotypes, Genome Biology 7(10) 10 (2006), no. 7. (cited on page 40).
[CMS06] T.P.S. Chan, P. Malik, and R. Singh, An interactive visualization-based
approach for high throughput screening information management in drug
discovery, Engineering in Medicine and Biology Society, 2006. EMBS ’06.
28th Annual International Conference of the IEEE, Aug 2006, pp. 5794–
5797. (cited on page 51).
[Cor88] F. Corpet, Multiple sequence alignment with hierarchical clustering., Nucleic
Acids Research 16 (1988), no. 22, 10881–10890. (cited on page 74).
[CYW+11] L. Cao, K. Yan, L. Winkel, M. de Graauw, and F.J. Verbeek, Pattern
recogntion in high-content cytomics screens for target discovery - case studies
in endocytosis, PRIB 2011, 2011. (cited on pages 28, 29, 30, 47, 48, 50, 81
and 91).
[DAJ12] S. K. Dubey, A. Anand, and H. Jangala, Laboratory information and man-
agement system: A tool to increase laboratory productivity, Clinical Research
and Regulatory Affairs 29 (2012), no. 2, 46 – 56. (cited on pages 20, 21
and 22).
Bibliography 101
[DC08] Ewa Deelman and Ann Chervenak, Data management challenges of data-
intensive scientific workflows, Proceedings of the 2008 Eighth IEEE Inter-
national Symposium on Cluster Computing and the Grid (Washington,
DC, USA), CCGRID ’08, IEEE Computer Society, 2008, pp. 687–692.
(cited on pages 16 and 17).
[dGCW+13] M. de Graauw, L. Cao, L. Winkel, M. H. A. M. van Miltenburg,
S. LeDévédec, M. Klop, K. Yan, C. Pont, V-M. Rogkoti, A. Tijsma,
A. Chaudhuri, R. Lalai, L. Price, F. Verbeek, and B. van de Water, An-
nexin a2 depletion delays egfr endocytic trafficking via cofilin activation and
enhances egfr signaling and metastasis formation, Oncogene (2013). (cited
on page 47).
[DGDLM13] Y. Demchenko, P. Grosso, C. De Laat, and P. Membrey, Addressing big
data issues in scientific data infrastructure, Collaboration Technologies and
Systems (CTS), 2013 International Conference on, May 2013, pp. 48–55.
(cited on page 18).
[Di13] Z. Di, Development of automatic image analysis methods for high-throughput
and high-content screening, Ph.d. thesis, Leiden University, Leiden, The
Netherlands, December 2013. (cited on page 14).
[EBG+12] Kevin W. Eliceiri, Michael R. Berthold, Ilya G. Goldberg, Luis Ibanez,
B. S. Manjunath, Maryann E. Martone, Robert F. Murphy, Hanchuan
Peng, Anne L. Plant, Badrinath Roysam, Nico Stuurman, Jason R. Swed-
low, Pavel Tomancak, and Anne E. Carpenter, Biological imaging software
tools, Nat Meth 9 (2012), no. 7, 697–710. (cited on pages 11, 12 and 13).
[FFM05] A. Fuxman, E. Fazli, and R. J. Miller, Conquer: Efficient management
of inconsistent databases, Proceedings of the 2005 ACM SIGMOD Inter-
national Conference on Management of Data (New York, NY, USA),
SIGMOD ’05, ACM, 2005, pp. 155–166. (cited on page 57).
[GAK+14] Robert Grandl, Ganesh Ananthanarayanan, Srikanth Kandula, Sriram
Rao, and Aditya Akella, Multi-resource packing for cluster schedulers, Pro-
ceedings of the 2014 ACM Conference on SIGCOMM (New York, NY,
USA), SIGCOMM ’14, ACM, 2014, pp. 455–466. (cited on page 81).
[GM07] Estelle Glory and Robert F. Murphy, Automated subcellular location deter-
mination and high-throughput microscopy, Developmental Cell 12 (2007),
no. 1, 7 – 16. (cited on page 12).
[GMNR05] M. Gudgin, N. Mendelsohn, M. Nottingham, and H. Ruellan, Soap
message transmission optimization mechanism, 2005. (cited on page 33).
[Gro10] The HDF Group, Hierarchical data format version 5, 2000-2010. (cited on
page 46).
102 Bibliography
[GW06] R. C. Gonzalez and R. E. Woods, Digital image processing (3rd edition),
Prentice-Hall, Inc., Upper Saddle River, NJ, USA, 2006. (cited on
page 82).
[Han02] G. Hannon, Rna interference, Nature 418 (2002), no. 6894, 244–251. (cited
on page 59).
[Hey02] Stephan Heyse, Comprehensive analysis of high-throughput screening data,
2002, pp. 535–547. (cited on page 18).
[HT03] T. Hey and A. Trefethen, The data deluge: An e-science perspective, pp. 809–
824, John Wiley Sons, Ltd, 2003. (cited on page 17).
[JZR+08] M. Johnson, I. Zaretskaya, Y. Raytselis, Y. Merezhuk, S. McGinnis, and
T. Madden, Ncbi blast: a better web interface, Nucleic Acids Research 36
(2008), no. suppl 2, W5–W9. (cited on page 60).
[KAEM13] Stephen Kaisler, Frank Armour, J. Alberto Espinosa, and William Money,
Big data: Issues and challenges moving forward, 2014 47th Hawaii Inter-
national Conference on System Sciences 0 (2013), 995–1004. (cited on
page 19).
[KBK+09] A. Kallergi, Y. Bei, P. Kok, J. Dijkstra, J.P. Abrahams, and F.J. Verbeek,
Cyttron: A virtualized microscope supporting image integration and knowledge
discovery, Cell Death and Disease Series: Proteins Killing Tumour Cells
(2009), 291 – 315. (cited on page 39).
[KBL+08] K. Kohl, G. Basler, A. Ludemann, J. Selbig, and D. Walther, A plant
resource and experiment management system based on the golm plant database
as a basic tool for omics research, Plant Methods 4 (2008), no. 1, 11. (cited
on page 51).
[KGG10] S. Kalani, D. Gupta, and R. Gupta, Good laboratory practices : compliance
using lims, no. 1, 41–43. (cited on page 22).
[Kos06] Kurt Kosanke, Iso standards for interoperability: a comparison, Interop-
erability of Enterprise Software and Applications (Dimitri Konstan-
tas, Jean-Paul Bourrières, Michel Léonard, and Nacer Boudjlida, eds.),
Springer London, 2006, pp. 55–64. (cited on page 17).
[Kri09] Wim P. Krijnen, Applied statistics for bioinformatics using r, 2009. (cited on
page 86).
[KS06] M. Keith and M. Schincariol, Pro ejb 3: Java persistence api (pro), Apress,
Berkely, CA, USA, 2006. (cited on pages 33 and 85).
[Lak99] Joseph R. Lakowicz, Principles of fluorescence spectroscopy, second ed.,
Kluwer Academic/Plenum Publishers, 1999. (cited on page 13).
Bibliography 103
[LC09] Vebjorn Ljosa and Anne E Carpenter, Introduction to the quantitative
analysis of two-dimensional fluorescence microscopy images for cell-based
screening, PLoS Computational Biology 5 (2009), no. 12, e1000603. (cited
on page 12).
[Lev66] V.I. Levenshtein, Binary codes capable of correcting deletions, insertions and
reversals, Soviet Physics Doklady 10 (1966), 707. (cited on pages 67
and 74).
[LYdB+10] S. LeDévédec, K. Yan, H. de Bont, V. Ghotra, H. Truong, E. Danen, F.J.
Verbeek, and B. van de Water, A systems microscopy approach to understand
cancer cell migration and metastasis, Journal of Cellular and Molecular in
Life Science (2010). (cited on pages 28, 30 and 31).
[LZCV14] E. Larios, Y. Zhang, L. Cao, and F.J. Verbeek, Cytomicsdb: A metadata-based
storage and retrieval approach for high-throughput screening experiments,
Pattern Recognition in Bioinformatics (Matteo Comin, Lukas Käll, Elena
Marchiori, Alioune Ngom, and Jagath Rajapakse, eds.), Lecture Notes
in Computer Science, vol. 8626, Springer International Publishing, 2014,
pp. 72–84. (cited on pages 54 and 85).
[LZY+12] E. Larios, Y. Zhang, K. Yan, Z. Di, S. LeDévédec, F. Groffen, and F.J.
Verbeek, Automation in cytomics: A modern rdbms based platform for image
analysis and management in high-throughput screening experiments, Pro-
ceedings of the 1st Int. Conf. on Health Information Science, vol. 7231,
2012, pp. 76–87. (cited on pages 42, 46, 54, 69, 71 and 80).
[MA04] R. T. Marler and J. S. Arora, Survey of multi-objective optimization methods
for engineering, Structural and Multidisciplinary Optimization 26 (2004),
no. 6, 369–395. (cited on pages 67 and 75).
[Mah91] R. R. Mahaffey, Information technology in the laboratory, Chemometrics
and Intelligent Laboratory Systems 13 (1991), no. 1, 69 – 74. (cited on
page 20).
[MAT10] MATLAB, version 7.10.0 (r2010a), The MathWorks Inc., Natick, Mas-
sachusetts, 2010. (cited on page 31).
[MCV+06] P. Malik, T. Chan, J. Vandergriff, J. Weisman, J. DeRisi, and R. Singh,
Information management and interaction in high-throughput screening for
drug discovery, Database Modeling in Biology: Practices and Challenges
(Z. Ma and J. Chen, eds.), Springer Verlag, 2006. (cited on page 53).
[MF08] L. Mayr and P. Fuerst, The future of high-throughput screening, Journal of
Biomolecular Screening (2008). (cited on page 41).
104 Bibliography
[Miz02] I. Mizrachi, Chapter 1 genbank: The nucleotide sequence database, The NCBI
Handbook [Internet] (J. McEntyre and J. Ostell, eds.), Bethesda (MD):
National Center for Biotechnology Information (US), 2002. (cited on
page 60).
[MKSP00] D. R. Maglott, K. S. Katz, H. Sicotte, and K. D. Pruitt, Ncbi’s locuslink
and refseq, Nucleic Acids Research 28 (2000), no. 1, 126–128. (cited on
page 63).
[Mon] Boost your data analytics, https://www.monetdbsolutions.com/
solutions/analytics, Accessed: 2015-02-23. (cited on page 86).
[Mot99] A. Motro, Multiplex: A formal model for multidatabases and its implemen-
tation, Next Generation Information Technologies and Systems (RonY.
Pinter and Shalom Tsur, eds.), Lecture Notes in Computer Science, vol.
1649, Springer Berlin Heidelberg, 1999, pp. 138–158 (English). (cited on
page 56).
[Mot01] , Data integration: Inconsistency detection and resolution based on
source properties, In Workshop on Foundations of Models for Information
Integration (FMII), 2001, pp. 429–444. (cited on page 57).
[NSD+10] D. Nix, T. Di Sera, B. Dalley, B. Milash, R. Cundick, K. Quinn, and
S. Courdy, Next generation tools for genomic data generation, distribution,
and visualization, BMC Bioinformatics 11 (2010), no. 1, 455. (cited on
page 51).
[NWH+10] B. Neumann, T. Walter, J.K. Hériché, J. Bulkescher, H. Erfle, C. Con-
rad, P. Rogers, I. Poser, M. Held, U. Liebel, C. Cetin, F. Sieckmann,
G. Pau, R. Kabbe, A. W’́unsche, V. Satagopam, M.H. Schmitz, C. Cha-
puis, D.W. Gerlich, R. Schneider, R. Eils, W. Huber, J.M. Peters, A.A.
Hyman, R. Durbin, R. Pepperkok, and J. Ellenberg, Phenotypic profiling
of the human genome by time-lapse microscopy reveals cell division genes,
Nature Apr 1 (2010), no. 464(7289), 721–727. (cited on page 31).
[O’N] Elizabeth J. O’Neil, Object/relational mapping 2008: Hibernate and the entity
data model (edm), Proceedings of the 2008 ACM SIGMOD International
Conference on Management of Data, SIGMOD ’08. (cited on page 33).
[PCC13] Pasquale Pagano, Leonardo Candela, and Donatella Castelli, Data inter-
operability, Data Science Journal 12 (2013), GRDI19–GRDI25. (cited on
page 18).
[Pok11] Jaroslav Pokorny, Nosql databases: A step to database scalability in web
environment, Proceedings of the 13th International Conference on In-
formation Integration and Web-based Applications and Services (New
York, NY, USA), iiWAS ’11, ACM, 2011, pp. 278–283. (cited on page 97).
Bibliography 105
[QSY+11] Y. Qin, G. Stokman, K. Yan, S. Ramaiahgari, F.J. Verbeek, B. van de Water,
and L. Price, Activation of epac-rap signaling protects against cisplatin-
induced apoptosis of mouse renal proximal tubular cells, Journal of Biological
Chemistry (2011), In Press. (cited on page 28).
[Say08] E. Sayers, E-utilities quick start. entrez programming utilities help [inter-
net], http://www.ncbi.nlm.nih.gov/books/NBK25500/, 2008,
Accessed: 2014 Oct 21. (cited on page 66).
[SKE07] Paul J. Smith, I.A. Khan, and R.J. Errington, Cytomics and drug develop-
ment, Cytometry Part A 71A (2007), no. 6, 349–351. (cited on pages 14,
16 and 17).
[SMS+02] P.T. Spellman, M. Miller, J. Stewart, C. Troup, U. Sarkans, S. Chervitz,
D. Bernhart, G. Sherlock, C. Ball, M. Lepage, M. Swiatek, W.L. Marks,
J. Goncalves, S. Markel, D. Iordan, M. Shojatalab, A. Pizarro, J. White,
R. Hubley, E. Deutsch, M. Senger, B.J. Aronow, A. Robinson, D. Bassett,
C.J. Stoeckert, and A. Brazma, Design and implementation of microar-
ray gene expression markup language (mage-ml), Genome Biology (2002),
no. 3(9):RESEARCH0046. (cited on page 39).
[Sta06] Garrick Staples, Torque resource manager, Proceedings of the 2006
ACM/IEEE Conference on Supercomputing (New York, NY, USA),
SC ’06, ACM, 2006. (cited on page 81).
[SZK+11] D.O. Skobelev, T.M. Zaytseva, A.D. Kozlov, V.L. Perepelitsa, and A.S.
Makarova, Laboratory information management systems in the work of the
analytic laboratory, Measurement Techniques 53 (2011), no. 10, 1182–1189.
(cited on page 20).
[TGDS04] Kerstin Thurow, Bernd Göde, Uwe Dingerdissen, and Norbert Stoll,
Laboratory information management systems for life science applications, Or-
ganic Process Research & Development 8 (2004), no. 6, 970–982. (cited
on page 20).
[Tox] Visualisation core facilities, http://toxicology.leidenuniv.nl/
research/facilities, Accessed: 2015-03-25. (cited on page 12).
[Whi09] Tom White, Hadoop: The definitive guide, 1st ed., O’Reilly Media, Inc.,
2009. (cited on page 97).
[WSP+07] M. Wendl, S. Smith, C. Pohl, D. Dooling, A. Chinwalla, K. Crouse,
T. Hepler, S. Leong, L. Carmichael, M. Nhan, B. Oberkfell, E. Mardis,
L. Hillier, and R. Wilson, Design and implementation of a generalized lab-
oratory data model, BMC Bioinformatics 8 (2007), no. 1, 362. (cited on
pages 42 and 51).
106 Bibliography
[Yan13] K. Yan, Image analysis and platform development for automated phenotyping
in cytomics, Ph.d. thesis, Leiden University, Leiden, The Netherlands,
November 2013. (cited on pages 31 and 82).
[YLL+11] K. Yan, E. Larios, S. LeDévédec, B. van de Water, and F.J. Verbeek, Au-
tomation in cytomics: Systematic solution for image analysis and management
in high throughput sequences, Proceedings IEEE Conf. Engineering and
Technology (CET 2011), vol. 7, 2011, pp. 195–198. (cited on pages 10, 11,
13, 14, 27, 32 and 83).
[YV12] K. Yan and F.J. Verbeek, Segmentation for high-throughput image analysis:
Watershed masked clustering, Proceedings of the 5th International Confer-
ence on Leveraging Applications of Formal Methods, Verification and
Validation: Applications and Case Studies - Volume Part II (Berlin, Hei-
delberg), ISoLA’12, Springer-Verlag, 2012, pp. 25–41. (cited on pages 48,
49, 80 and 81).
[YVDvdW09] K. Yan, F. J. Verbeek, S. Le Dévédec, and B. van de Water, Cell tracking
and data analysis of in vitro tumour cells from time-lapse image sequences.,
VISAPP (1) (Alpesh Ranchordas and Helder Araújo, eds.), INSTICC
Press, 2009, pp. 281–286. (cited on pages 28, 30, 80 and 81).
[YXQZZH12] Z. Yong-Xin, L. Qing-Zhong, and P. Zhao-Hui, Two-stage data conflict
resolution based on markov logic networks, Chinese Journal of Computers
(2012). (cited on page 56).
Summary
In biomedical research, the study of cellular systems on large scale is called Cytomics.
High-Throughput screening (HTS) is one of the most common techniques for target
validation; it allows testing a large number of chemicals against disease targets for
identifying hits. Moreover, an HTS environment is composed by a diversity of com-
ponents that have to face challenges in terms of managing large volume of data, data
heterogeneity, no integrated complex hardware architecture, diversity of software tools,
managing protocols, etc. Therefore, this current scenario is pushing forward the need
to develop a comprehensive data management platform for experiments in Cytomics.
This new approach should be capable to enhance: (1) exploration of large volumes of
data, (2) interoperability, (3) understandability, and (4) sharing and reusability of the
data.
In this thesis, in four chapters our research on the development of CytomicsDB
is described. This constitutes a platform which integrates the whole HTS workflow
into a single system. An automated HTS workflow has been proposed to speed
up the processes from plate design to image and data analysis. Chapter 2 focuses
on the architecture of CytomicsDB, which relies on a modern relational database
system, capable to integrate to other legacy systems used in HTS environments or other
external repositories for data validation. The architecture also promotes data sharing
and collaboration using several security roles, which allow scientist to publish their
data or grant access to other researchers to their own experiments.
In Chapter 3, we further elaborate our approach in the metadata management
performed by CytomicsDB. A semantic layer has been built in order to facilitate
the understandability and exploration of the large volume of images and metadata
involved in HTS experiments and at the same time allowing scientists to integrate new
tools and APIs taking care of the image and data analysis. These results will become
part of the experiments metadata and will be available for semantic post analysis.
In Chapter 4, we introduce the validation process as performed in CytomicsDB.
Management of the HTS information is one of the key challenges for drug discovery
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and in order to ensure consistency, integrity and reliability of the data stored in the
platform it is compulsory to perform a strict validation process in every stage of the HTS
workflow. CytomicsDB facilitates this validation process using web services, which
will prove each critical entry with an internal or external repository. The metadata that
we store become a key parameter for performing further image/data analysis and drill
down the results of different experiments datasets.
Chapter 5 describes the integration of CytomicsDB architecture to the Leiden
Life Sciences Cluster (LLSC) and the environment for data processing provided by
MonetDB. In this new environment the image analysis algorithms need to be adapted,
and the performance of the resulting parallelized algorithms is evaluated. The steps
involved in this stage are also further elaborated in a image and data analysis data
flow.
The current challenges in HTS experiments are pushing forward the need to design
and develop more complex platforms for Cytomics, which are capable to adapt to the
continuous changes presented in its environment. CytomicsDB’s architecture facili-
tates the integration with other systems involved in HTS experiments. Moreover, the
metadata has been organized in order to have a common data model, which enhances
understandability, collaboration and data sharing. In CytomicsDB, the validation of
the metadata stored in the repository is considered a key process. The consistency of
metadata is guaranteed by accessing external biological databases that are supported
and maintained by the scientific community. Finally, our platform integrates the advan-
tages of clustering computing for the image analysis stage and also the data processing
functionality provided my MonetDB.R package to speed up the data analysis avoiding
the movement of huge amounts of data for processing.
Samenvatting
In biomedisch onderzoek wordt veelvuldig gebruik gemaakt van celculturen in het
onderzoek. Het onderzoeksveld waarin op grote schaal gebruik gemaakt wordt van
cel-systemen wordt aangeduid met Cytomics. High-Throughput Screening (HTS) is
een van de meest gebruikte technieken in Cytomics voor het valideren van potentiële
kandidaat “targets” voor de ontwikkeling van medicijnen. Hierbij kunnen binnen
een experiment grote hoeveelheden verschillende chemische verbindingen worden
getest die een cruciale rol spelen in een ziektebeeld en daarmee kandidaat zijn voor het
ontwikkelen van medicijnen tegen deze ziekte. Een omgeving voor High-Throughput
Screening is samengesteld uit een aantal componenten die onderling samenhang
moeten vertonen. Voor een succesvolle toepassing van een dergelijke omgeving zijn
er een aantal complicaties die moeten worden overwonnen: (1) het beheren van
grote hoeveelheden data, (2) interoperabiliteit, (3) begrijpbaarheid en (4) het delen het
hergebruik van data.
In dit proefschrift wordt in 4 hoofdstukken het onderzoek beschreven voor de
ontwikkeling van een platform voor onderzoek en beheer van data, genaamd Cy-
tomicsDB, waarbij de gehele keten van werkzaamheden, het werkproces, in een sys-
teem wordt ondergebracht. Een geautomatiseerde keten van werkzaamheden wordt
voorgesteld waarmee een versnelling van de werkzaamheden teweeg kan worden
gebracht; van het begin van het traject bij ontwerp van het experiment tot de data
analyse aan het einde van het traject.
In Hoofdstuk 1 wordt een algemene inleiding geven van het werkveld en de con-
cepten die van belang zijn voor het onderzoek. In Hoofdstuk 2 wordt een architectuur
beschreven die voor CytomicsDB wordt gebruikt en dit gebaseerd is op een modern
relationeel database systeem. Met een dergelijk systeem kunnen bestaande, maar deels
verouderde systemen, zogenaamde legacy systemen, worden geïntegreerd; dit zijn
de systemen die momenteel in HTS worden gebruikt, maar ook externe opslagsyste-
men die belangrijk zijn voor de validatie van de data. De voorgestelde architectuur
is zeer geschikt voor het delen van data en samenwerking, waarbij verschillende
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niveaus van beveiliging van de data zijn ingevoerd die de wetenschapper in staat
stellen data te publiceren voor de gehele gemeenschap of juist alleen een selecte groep
mede-onderzoekers toegang te geven tot deze data.
Naast data zijn er gegevens over de data, bijvoorbeeld, hoe deze data tot stand zijn
gekomen. Deze gegevens worden ook Metadata genoemd, in feite zijn dit eigenlijk data
over data. In Hoofdstuk 3 wordt een strategie uitgewerkt voor het beheer van metadata
zoals dat in CytomicsDB is ingebed. Er is een semantische schil geconstrueerd waarmee
begrijpbaarheid en exploratie van grote volumina data en metadata de betrokken zijn
bij een HTS experiment te faciliteren. Tegelijkertijd stelt deze semantische schil de
wetenschapper in staat om nieuwe methoden en programma’s te integreren waarmee
de beeld- en data-analyse kan worden afgehandeld. De resultaten uit deze analyses
zullen deel worden van de experiment metadata en komen beschikbaar voor een post
data-analyse op een semantisch niveau.
In Hoofdstuk 4 introduceren we het proces van data validatie zoals dat in Cy-
tomicsDB wordt uitgevoerd. Het beheer van de HTS informatie is een van de belangri-
jkste uitdagingen bij het ontdekken van nieuwe medicijnen. Teneinde de consistentie,
integriteit en betrouwbaarheid van de data opgeslagen in CytomicsDB te garanderen,
is het verplicht in iedere stap van het HTS werkproces een nauwgezette validatie uit
te voeren. In CytomicsDB wordt deze validatiestap gefaciliteerd door middel van
web-services waarmee iedere nieuwe kritische invoer van data wordt getest aan de
hand van een interne of externe opslagsystemen.
In Hoofdstuk 5 wordt de integratie van de CytomicsDB architectuur met een reken-
cluster, de Leiden Life Sciences Cluster (LLSC), beschreven in samenhang met de
omgeving voor data processing die aanwezig is binnen het MonetDB database man-
agement system. Voor het efficiënt gebruik van het rekencluster moeten de algoritmen
voor beeldanalyse worden aangepast. Deze parallellisatieslag is geëvalueerd en de
prestaties van de herschreven algoritmen worden gepresenteerd. De stappen de be-
trokken zijn bij de analyses worden verder uitgewerkt in een werkproces voor beeld-
en data-analyse.
De huidige stand van zaken in HTS experimenten is de uitdaging aan te gaan in de
behoefte te kunnen voorzien om complexere platforms voor Cytomics te ontwikkelen
waarmee ingewikkelde experimenten kunnen worden geanalyseerd en die zich kun-
nen aanpassen aan de continue veranderingen in het Cytomics veld. De architectuur
van CytomicsDB faciliteert de integratie van met andere systemen die binnen HTS
experimenten gebruikt worden. De metadata zijn, bovendien, zodanig georganiseerd
dat ze voldoen aan een algemeen data-model waardoor de begrijpbaarheid, samen-
werking en het delen van data sterk verbeterd is. De validatie van de metadata die in
CytomicsDB worden opgeslagen is wordt een sleutel proces, de consistentie van deze
metadata wordt verzekerd door een dubbele controle met data uit andere databanken
die door de gemeenschap worden beheerd. Tot slot, het platform dat in dit proefschrift
wordt gepresenteerd, integreert de voordelen van het toepassen van de beeldanalyse
op rekenclusters en daarnaast het gebruik van de functionaliteit voor dataverwerking
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die in MonetDB is gebouwd met het softwarepakket MonetDB.R. Hiermee kan een
aanzienlijke winst worden behaald met het verwerken van de data waarbij voorkomen
wordt dat er heel veel data moeten worden verplaatst voor de verwerking.
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